Innovation,Alternative Names,Category,Disease,Indication,Stage,trial_completion_date,TargetPop,is_on_fda,dates_fda,records_fda,time_to_regulatory_approval,time_approval_to_first_launch,time_launch_to_20lmic,time_to_market,expected_date_of_regulatory_approval,expected_date_of_first_launch,expected_date_of_market,Readiness,LeadOrg,Impact Score,Country,Impact Potential,Disease Burden,Epidemiological impact,Alignment with goals,Cost-effectiveness,Budget Impact,Resource optimization,Introduction Readiness,Financing,Policy,Uptake/Delivery,Probability of technical and regulatory success,Procurement model,Regulatory approvals,Policy readiness,Social context,Guidelines and training,Policy implemented,Advance launch and planning/timeline,Demand forecasting and generation,Potential supply chain,Delivery model
Placebo,Molecule Z,Drug,Malaria,Malaria,Phase 4,2022-06-01,"Sex: ALL; Age: >8 Days; Criteria: Inclusion Criteria:

* Between 8 days and 59 months old
* Primary residence within catchment area of study site
* Available for full 6 month study
* No known allergy to macrolides/azalides
* Appropria...",No,2022-10-27,FDA-31883,0.56,0.15,3.5,4.21,2022-12-22,2023-02-15,2026-08-16,34,GSK,36,Kenya,46.83333333,87,12,56,7,50,69,27,0,2,1,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE
Artemether-lumefantrine,AltName B,Drug,Malaria,Malaria,Phase 4,2021-08-31,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

1, All participants:

1. Residency within 60 km of the study clinics either at TDH or at MGH
2. Agreement to come to clinic for all follow-up clinical and PK evaluations
3. Provis...",Yes,2022-03-15,FDA-41498,0.56,0.15,3.5,4.21,2022-03-23,2022-05-17,2025-11-15,3,Bayer,23,Overall,48.66666667,93,83,2,70,15,29,55,1,3,2,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE
Primaquine,Product Alpha,Drug,Malaria,Malaria,Phase 4,2015-03-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

* Age ³ 12 months
* P. vivax or P. falciparum monoinfection or P.v. / P.f. mixed infection
* Presence of axillary temperature ³ 37.5¡C or history of fever during the past 24 hrs
*...",Yes,2015-04-13,FDA-88023,0.56,0.15,3.5,4.21,2015-09-21,2015-11-15,2019-05-16,84,Sanofi,87,Overall,59.33333333,35,71,23,79,68,80,45,0,4,1,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
Artemether-lumefantrine combination,Product Alpha,Drug,Malaria,Malaria,Phase 4,2015-03-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

* Age ³ 12 months
* P. vivax or P. falciparum monoinfection or P.v. / P.f. mixed infection
* Presence of axillary temperature ³ 37.5¡C or history of fever during the past 24 hrs
*...",No,2015-07-29,FDA-57908,0.56,0.15,3.5,4.21,2015-09-21,2015-11-15,2019-05-16,78,Bayer,68,Kenya,47.5,69,24,66,9,37,80,73,2,4,2,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE
chloroquine,Molecule Z,Drug,Malaria,Malaria,Phase 4,2015-03-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

* Age ³ 12 months
* P. vivax or P. falciparum monoinfection or P.v. / P.f. mixed infection
* Presence of axillary temperature ³ 37.5¡C or history of fever during the past 24 hrs
*...",No,2015-08-05,FDA-90865,0.56,0.15,3.5,4.21,2015-09-21,2015-11-15,2019-05-16,86,Pfizer,62,Overall,63.83333333,52,56,83,63,92,37,45,1,2,2,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE
Artesunate-mefloquine,Comp Beta,Drug,Malaria,Malaria,Phase 4,2008-11-01,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria

* 12 years of age or older
* Accepts Healthy Volunteers
* P. falciparum parasitemia between 1,000 and 100,000 parasites/_l
* History of fever or presence of fever (temperature ³ 37...",Yes,2009-08-14,FDA-31643,0.56,0.15,3.5,4.21,2009-05-24,2009-07-18,2013-01-16,88,Bayer,90,Senegal,56.66666667,19,99,12,70,90,50,27,1,1,1,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE
Azithromycin,AltName B,Drug,Malaria,Malaria,Phase 4,2022-06-01,"Sex: ALL; Age: >8 Days; Criteria: Inclusion Criteria:

* Between 8 days and 59 months old
* Primary residence within catchment area of study site
* Available for full 6 month study
* No known allergy to macrolides/azalides
* Appropria...",No,2023-04-05,FDA-92577,0.56,0.15,3.5,4.21,2022-12-22,2023-02-15,2026-08-16,76,Sanofi,37,Kenya,38.33333333,19,75,42,48,12,34,55,1,2,3,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE
COA566,GenName Y,Drug,Malaria,Malaria,Phase 4,2012-07-01,"Sex: ALL; Criteria: Inclusion:

* Subjects who were diagnosed as Asymptomatic Carrier (AC) by Rapid Diagnostic Test (RDT).
* Subjects who were diagnosed with a Symptomatic malaria episode, RDT-confirmed (SMRC)

Exclusion...",No,2013-04-25,FDA-91778,0.56,0.15,3.5,4.21,2013-01-21,2013-03-17,2016-09-15,1,Bayer,11,Kenya,46.83333333,15,11,68,91,25,71,55,1,3,2,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE
Atovaquone-proguanil,GenName Y,Drug,Malaria,Malaria,Phase 4,2008-11-01,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria

* 12 years of age or older
* Accepts Healthy Volunteers
* P. falciparum parasitemia between 1,000 and 100,000 parasites/_l
* History of fever or presence of fever (temperature ³ 37...",No,2008-12-27,FDA-10272,0.56,0.15,3.5,4.21,2009-05-24,2009-07-18,2013-01-16,57,J&J,92,Overall,42.33333333,68,18,58,21,9,80,55,1,3,2,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE
Proguanil Oral Tablet,AltName B,Drug,Malaria,Malaria,Phase 4,2020-12-16,"Sex: ALL; Age: >1 Year; Criteria: Inclusion Criteria:

* Age greater than 12 months and less than 10 years at enrollment;
* Current attendance at or willingness to attend the study SCA clinic at HBCH;
* Residence in either Homa Bay Co...",Yes,2021-02-13,FDA-37872,0.56,0.15,3.5,4.21,2021-07-08,2021-09-01,2025-03-02,22,Merck,59,Senegal,37,63,71,79,3,0,6,55,1,3,2,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE
primaquine,Comp Beta,Drug,Malaria,Malaria,Phase 4,2018-10-21,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Previous G6PD test at Shoklo Malaria Research Unit (SMRU) clinic with one of following results: 1) G6PD homozygous wildtype females (G6PD genotype normal) 2) G6PD heterozygous f...",No,2019-06-04,FDA-33807,0.56,0.15,3.5,4.21,2019-05-13,2019-07-07,2023-01-05,56,GSK,84,South Africa,45.16666667,21,40,38,27,99,46,64,1,4,2,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
chloroquine + primaquine,AltName B,Drug,Malaria,Malaria,Phase 4,2018-10-21,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Previous G6PD test at Shoklo Malaria Research Unit (SMRU) clinic with one of following results: 1) G6PD homozygous wildtype females (G6PD genotype normal) 2) G6PD heterozygous f...",No,2018-12-10,FDA-77404,0.56,0.15,3.5,4.21,2019-05-13,2019-07-07,2023-01-05,39,Gilead,9,Overall,59.66666667,12,38,95,77,77,59,55,1,2,3,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE
Sulfadoxine/Pyrimethanine-Amodiaquine (SP-AQ),TradeName X,Drug,Malaria,Malaria,Phase 4,2020-12-16,"Sex: ALL; Age: >1 Year; Criteria: Inclusion Criteria:

* Age greater than 12 months and less than 10 years at enrollment;
* Current attendance at or willingness to attend the study SCA clinic at HBCH;
* Residence in either Homa Bay Co...",Yes,2021-11-22,FDA-73983,0.56,0.15,3.5,4.21,2021-07-08,2021-09-01,2025-03-02,37,Gilead,8,South Africa,74.83333333,61,72,70,82,70,94,36,1,1,2,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE
Dihydroartemisinin-Piperaquine (DP),Product Alpha,Drug,Malaria,Malaria,Phase 4,2020-12-16,"Sex: ALL; Age: >1 Year; Criteria: Inclusion Criteria:

* Age greater than 12 months and less than 10 years at enrollment;
* Current attendance at or willingness to attend the study SCA clinic at HBCH;
* Residence in either Homa Bay Co...",Yes,2021-05-22,FDA-97530,0.56,0.15,3.5,4.21,2021-07-08,2021-09-01,2025-03-02,45,Novartis,21,Kenya,70.83333333,28,91,75,94,85,52,45,1,2,2,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE
Dihydroartemisinin-piperaquine,Molecule Z,Drug,Malaria,Malaria,Phase 4,2022-04-11,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

All participants:

* Agreement to come to clinic for all follow-up PK and safety evaluations
* Provision of informed consent.

HIV-infected participants:

* Residency within 30km ...",No,2022-09-05,FDA-31303,0.56,0.15,3.5,4.21,2022-11-01,2022-12-26,2026-06-26,62,Novartis,72,Overall,56.5,31,64,28,94,78,44,55,1,5,0,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
"RTS,S/AS01",Comp Beta,Biological,Malaria,Malaria,Phase 3,2022-03-31,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* The child had been enrolled in the initial phase of the trial of seasonal vaccination with the RTS,S/AS01 vaccine
* A parent or legally recognised guardian provides informed con...",No,2023-01-20,FDA-19051,2.62,0.32,5,7.94,2024-11-11,2025-03-08,2030-03-09,80,Novartis,91,South Africa,44.5,30,50,30,48,89,20,64,1,3,3,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE
SMC placebo,Molecule Z,Drug,Malaria,Malaria,Phase 3,2022-03-31,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* The child had been enrolled in the initial phase of the trial of seasonal vaccination with the RTS,S/AS01 vaccine
* A parent or legally recognised guardian provides informed con...",Yes,2022-11-27,FDA-72531,2.62,0.32,5,7.94,2024-11-11,2025-03-08,2030-03-09,49,Sanofi,68,Kenya,39.33333333,50,63,11,84,14,14,55,1,4,1,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE
SMC with SP+AQ,Comp Beta,Drug,Malaria,Malaria,Phase 3,2022-03-31,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* The child had been enrolled in the initial phase of the trial of seasonal vaccination with the RTS,S/AS01 vaccine
* A parent or legally recognised guardian provides informed con...",No,2022-11-26,FDA-16866,2.62,0.32,5,7.94,2024-11-11,2025-03-08,2030-03-09,30,Bayer,70,Kenya,51,62,83,25,40,63,33,82,2,4,3,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE
Artefenomel 800mg: piperaquine 640mg,GenName Y,Drug,Malaria,Malaria,Phase 3,2015-11-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

1. Male or female patient age \>6 months \<70 years.
2. Body weight \>5 kg \<90 kg.
3. Presence of mono-infection of P. falciparum with:

   1. Fever, as defined by axillary tempe...",No,2016-01-13,FDA-98292,2.62,0.32,5,7.94,2018-06-14,2018-10-09,2023-10-10,45,AstraZeneca,90,South Africa,59,25,57,81,40,67,84,73,2,3,3,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE
Artefenomel 800mg: piperaquine 960mg,Comp Beta,Drug,Malaria,Malaria,Phase 3,2015-11-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

1. Male or female patient age \>6 months \<70 years.
2. Body weight \>5 kg \<90 kg.
3. Presence of mono-infection of P. falciparum with:

   1. Fever, as defined by axillary tempe...",No,2016-07-18,FDA-40516,2.62,0.32,5,7.94,2018-06-14,2018-10-09,2023-10-10,38,AstraZeneca,13,Overall,55.5,86,34,26,66,65,56,45,2,2,1,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
Coartem¨ (artemether lumefantrine),Molecule Z,Drug,Malaria,Malaria,Phase 3,2008-05-01,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* Male or female patients between the age of 3 and 60 years, inclusive.
* Body weight between 20 kg and 90 kg with no clinical evidence of severe malnutrition.
* Presence of acute...",No,2008-08-04,FDA-94396,2.62,0.32,5,7.94,2010-12-13,2011-04-09,2016-04-09,3,Sanofi,2,South Africa,45,20,81,49,15,92,13,27,0,2,1,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
Artefenomel 800mg: piperaquine 1440mg,Comp Beta,Drug,Malaria,Malaria,Phase 3,2015-11-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

1. Male or female patient age \>6 months \<70 years.
2. Body weight \>5 kg \<90 kg.
3. Presence of mono-infection of P. falciparum with:

   1. Fever, as defined by axillary tempe...",Yes,2016-01-05,FDA-82200,2.62,0.32,5,7.94,2018-06-14,2018-10-09,2023-10-10,19,Bayer,70,Kenya,48.5,34,90,25,12,76,54,45,1,2,2,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
Tetanus/diphtheria toxoids,AltName A,Biological,Malaria,Malaria,Phase 3,2022-03-31,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* The child had been enrolled in the initial phase of the trial of seasonal vaccination with the RTS,S/AS01 vaccine
* A parent or legally recognised guardian provides informed con...",Yes,2022-06-02,FDA-31754,2.62,0.32,5,7.94,2024-11-11,2025-03-08,2030-03-09,73,GSK,39,Overall,34.83333333,73,0,69,41,14,12,55,1,3,2,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE
arthemeter lumefantrine,AltName A,Drug,Malaria,Malaria,Phase 3,2008-11-01,"Sex: ALL; Criteria: Inclusion Criteria:

1. Male or female patients ²12 years of age.
2. Body weight ³ 5 kg and \< 25 kg with no clinical evidence of severe malnutrition (defined as a child whose weight-for-height is bel...",No,2009-07-01,FDA-81667,2.62,0.32,5,7.94,2011-06-15,2011-10-10,2016-10-10,94,Sanofi,10,Senegal,43.33333333,30,75,29,41,5,80,45,1,3,1,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE
Pyronaridine artesunate,Molecule Z,Drug,Malaria,Malaria,Phase 3,2008-05-01,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* Male or female patients between the age of 3 and 60 years, inclusive.
* Body weight between 20 kg and 90 kg with no clinical evidence of severe malnutrition.
* Presence of acute...",No,2008-11-13,FDA-33795,2.62,0.32,5,7.94,2010-12-13,2011-04-09,2016-04-09,38,AstraZeneca,64,Overall,65,88,23,73,94,13,99,55,1,2,3,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE
RABIPUR¨,GenName Y,Biological,Malaria,Malaria,Phase 3,2020-03-31,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* The child is a permanent resident of the study area and likely to remain a resident for the duration of the trial
* The child is 5 - 17 months of age at the time of first vaccin...",No,2020-05-14,FDA-43229,2.62,0.32,5,7.94,2022-11-12,2023-03-09,2028-03-09,85,Sanofi,47,Overall,60.33333333,28,92,70,88,69,15,55,1,3,2,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE
Dihydroartemisinin-piperaquine (DP),Comp Beta,Drug,Malaria,Malaria,Phase 3,2024-07-28,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Viable singleton pregnancy confirmed by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV- uninfected by rapid test
4. 16 years of age or older...",Yes,2025-04-15,FDA-79227,2.62,0.32,5,7.94,2027-03-11,2027-07-06,2032-07-06,14,Gilead,86,South Africa,47.66666667,51,50,59,29,35,62,64,2,3,2,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE
Sulfadoxine-pyrimethamine (SP),Comp Beta,Drug,Malaria,Malaria,Phase 3,2024-07-28,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Viable singleton pregnancy confirmed by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV- uninfected by rapid test
4. 16 years of age or older...",Yes,2025-07-17,FDA-14894,2.62,0.32,5,7.94,2027-03-11,2027-07-06,2032-07-06,64,GSK,37,Kenya,53,94,38,23,83,0,80,36,0,2,2,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE
Matched-Placebo for Tafenoquine,Molecule Z,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2019-10-09,FDA-26481,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,77,GSK,95,South Africa,51.33333333,11,93,22,71,64,47,55,1,1,4,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
pyronaridine artesunate,GenName Y,Drug,Malaria,Malaria,Phase 3,2008-11-01,"Sex: ALL; Criteria: Inclusion Criteria:

1. Male or female patients ²12 years of age.
2. Body weight ³ 5 kg and \< 25 kg with no clinical evidence of severe malnutrition (defined as a child whose weight-for-height is bel...",Yes,2009-03-28,FDA-25523,2.62,0.32,5,7.94,2011-06-15,2011-10-10,2016-10-10,51,GSK,62,South Africa,45.33333333,44,10,77,100,38,3,45,2,2,1,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE
Quinine,Product Alpha,Drug,Malaria,Malaria,Phase 3,2012-09-01,"Sex: ALL; Criteria: Inclusion Criteria:

1. The patient's legally acceptable representative has provided informed consent and the patient has assented (where relevant) to participation in the trial
2. The patient is a ch...",Yes,2013-02-09,FDA-88396,2.62,0.32,5,7.94,2015-04-15,2015-08-10,2020-08-10,6,Sanofi,100,Overall,53.16666667,62,64,15,2,87,89,36,1,2,1,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE
Artemether Sublingual Spray,AltName A,Drug,Malaria,Malaria,Phase 3,2012-09-01,"Sex: ALL; Criteria: Inclusion Criteria:

1. The patient's legally acceptable representative has provided informed consent and the patient has assented (where relevant) to participation in the trial
2. The patient is a ch...",Yes,2013-03-28,FDA-21074,2.62,0.32,5,7.94,2015-04-15,2015-08-10,2020-08-10,99,Novartis,27,Kenya,43.83333333,73,7,8,77,84,14,45,1,2,2,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
artemether:lumefantrine (2.5 mg:30 mg),TradeName X,Drug,Malaria,Malaria,Phase 3,2024-05-10,"Sex: ALL; Criteria: Inclusion Criteria:

1. Male or female neonates/infants
2. Body weight \<5 kg but ³ 2 kg
3. In Cohort 1, infants aged \>28 days; in Cohort 2, neonates aged 1 to ²28 days (3 subgroups: 1-7 days; 8-14 d...",Yes,2025-01-01,FDA-79653,2.62,0.32,5,7.94,2026-12-22,2027-04-18,2032-04-18,98,J&J,70,Overall,48,10,8,66,89,35,80,55,1,2,3,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
Chloroquine,Product Alpha,Drug,Malaria,Malaria,Phase 3,2010-11-15,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

1. Male or female patients between the age of 3 and 60 years, inclusive.
2. Body weight between 20 kg and 90 kg with no clinical evidence of severe malnutrition.
3. Presence of ac...",Yes,2011-01-30,FDA-52064,2.62,0.32,5,7.94,2013-06-28,2013-10-23,2018-10-24,39,Novartis,91,South Africa,47.66666667,48,47,8,85,33,65,64,1,3,3,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE
Pyronaridine - artesunate,Molecule Z,Drug,Malaria,Malaria,Phase 3,2010-11-15,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

1. Male or female patients between the age of 3 and 60 years, inclusive.
2. Body weight between 20 kg and 90 kg with no clinical evidence of severe malnutrition.
3. Presence of ac...",No,2011-11-10,FDA-89769,2.62,0.32,5,7.94,2013-06-28,2013-10-23,2018-10-24,5,J&J,48,Overall,67.5,78,93,40,68,82,44,45,1,2,2,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE
Tafenoquine,Molecule Z,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2020-05-26,FDA-85614,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,40,J&J,95,Senegal,47,74,40,84,51,19,14,55,1,4,1,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE
Dihydroartemisinin-piperaquine (DHA-PQP),Comp Beta,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2019-10-26,FDA-85373,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,0,GSK,46,South Africa,32.16666667,29,36,39,26,56,7,27,0,1,2,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
Matched-Placebo for Primaquine,Comp Beta,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2020-01-06,FDA-75781,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,40,Gilead,16,Kenya,54.33333333,70,94,77,2,26,57,64,1,3,3,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
TACT,AltName B,Drug,Malaria,Malaria,Phase 3,2020-03-04,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Male or female, aged from 2 years to 65 years old
* Acute uncomplicated P. falciparum malaria, confirmed by positive blood smear with asexual forms of P. falciparum (or mixed wi...",Yes,2020-07-06,FDA-73630,2.62,0.32,5,7.94,2022-10-16,2023-02-10,2028-02-11,67,Gilead,80,Kenya,69.16666667,89,89,28,76,78,55,55,1,2,3,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE
Lopinavir/Ritonavir (LPV/r),GenName Y,Drug,Malaria,Malaria,Phase 3,2013-01-01,"Sex: ALL; Age: >2 Months; Criteria: Inclusion criteria:

1. Age 2 months to \< 11 years
2. Confirmed HIV diagnosis. i. Children \> 18 months: Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Wester...",Yes,2013-09-19,FDA-37044,2.62,0.32,5,7.94,2015-08-15,2015-12-10,2020-12-10,51,Sanofi,98,Senegal,56.66666667,57,94,66,11,55,57,45,1,3,1,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE
Nevirapine (NVP),Comp Beta,Drug,Malaria,Malaria,Phase 3,2013-01-01,"Sex: ALL; Age: >2 Months; Criteria: Inclusion criteria:

1. Age 2 months to \< 11 years
2. Confirmed HIV diagnosis. i. Children \> 18 months: Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Wester...",Yes,2013-12-10,FDA-73160,2.62,0.32,5,7.94,2015-08-15,2015-12-10,2020-12-10,43,J&J,56,Senegal,55.5,55,92,39,2,95,50,36,1,3,0,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
Efavirenz (EFV),AltName B,Drug,Malaria,Malaria,Phase 3,2013-01-01,"Sex: ALL; Age: >2 Months; Criteria: Inclusion criteria:

1. Age 2 months to \< 11 years
2. Confirmed HIV diagnosis. i. Children \> 18 months: Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Wester...",No,2013-09-20,FDA-82006,2.62,0.32,5,7.94,2015-08-15,2015-12-10,2020-12-10,40,Merck,70,Overall,49.5,11,80,13,30,69,94,55,1,3,2,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE
2 nucleoside reverse transcriptase inhibitor (NRTI),GenName Y,Drug,Malaria,Malaria,Phase 3,2013-01-01,"Sex: ALL; Age: >2 Months; Criteria: Inclusion criteria:

1. Age 2 months to \< 11 years
2. Confirmed HIV diagnosis. i. Children \> 18 months: Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Wester...",No,2013-03-25,FDA-96524,2.62,0.32,5,7.94,2015-08-15,2015-12-10,2020-12-10,89,Novartis,17,Senegal,68,54,100,80,75,57,42,64,2,3,2,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE
Ivermectin,Product Alpha,Drug,Malaria,Malaria,Phase 3,2015-12-01,"Sex: ALL; Criteria: Inclusion Criteria:

* Residence in the study site
* Able to understand the information and willing to give consent and assent (parent or guardian consent if study participant age is \< 18 years)

Exc...",Yes,2016-05-06,FDA-19311,2.62,0.32,5,7.94,2018-07-14,2018-11-08,2023-11-09,57,Bayer,6,Kenya,42.83333333,25,43,88,4,2,95,45,0,3,2,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
Albendazole,GenName Y,Drug,Malaria,Malaria,Phase 3,2015-12-01,"Sex: ALL; Criteria: Inclusion Criteria:

* Residence in the study site
* Able to understand the information and willing to give consent and assent (parent or guardian consent if study participant age is \< 18 years)

Exc...",Yes,2016-06-03,FDA-34352,2.62,0.32,5,7.94,2018-07-14,2018-11-08,2023-11-09,1,Sanofi,49,Kenya,47.66666667,54,23,31,93,17,68,55,2,3,1,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE
Monthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS),GenName Y,Drug,Malaria,Malaria,Phase 3,2016-05-26,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Intrauterine pregnancy confirmed by ultrasound
2. Estimated gestational age between 12-28 weeks
3. Confirmed to be HIV-infected by Uganda country standard rapid HIV test
4. 16 ...",Yes,2017-05-23,FDA-60977,2.62,0.32,5,7.94,2019-01-07,2019-05-04,2024-05-04,72,Sanofi,30,South Africa,55.66666667,18,38,26,94,74,84,64,1,3,3,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
Monthly placebo + daily trimethoprim/sulfamethoxazole (TS),AltName A,Drug,Malaria,Malaria,Phase 3,2016-05-26,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Intrauterine pregnancy confirmed by ultrasound
2. Estimated gestational age between 12-28 weeks
3. Confirmed to be HIV-infected by Uganda country standard rapid HIV test
4. 16 ...",Yes,2017-04-02,FDA-54387,2.62,0.32,5,7.94,2019-01-07,2019-05-04,2024-05-04,74,J&J,17,Kenya,27.33333333,43,38,15,17,45,6,36,0,2,2,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE
sulfadoxine-pyrimethamine,Product Alpha,Drug,Malaria,Malaria,Phase 3,2008-06-01,"Sex: ALL; Age: >8 Years; Criteria: Inclusion Criteria:

* Age ³ 8 to \< 14 years (boys), ³ 8 to \< 12 years (girls)
* Student enrolled at participating school in classes 3-7
* Provision of informed consent from parent or guardian
* Pro...",No,2009-05-02,FDA-10312,2.62,0.32,5,7.94,2011-01-13,2011-05-10,2016-05-10,65,J&J,23,South Africa,51,53,94,34,21,20,84,55,1,1,4,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE
amodiaquine + sulfadoxine-pyrimethamine,GenName Y,Drug,Malaria,Malaria,Phase 3,2008-06-01,"Sex: ALL; Age: >8 Years; Criteria: Inclusion Criteria:

* Age ³ 8 to \< 14 years (boys), ³ 8 to \< 12 years (girls)
* Student enrolled at participating school in classes 3-7
* Provision of informed consent from parent or guardian
* Pro...",Yes,2009-04-07,FDA-56460,2.62,0.32,5,7.94,2011-01-13,2011-05-10,2016-05-10,61,Pfizer,95,Overall,40.33333333,0,52,29,1,65,95,64,1,3,3,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE
dihydroartemisinin-piperaquine,TradeName X,Drug,Malaria,Malaria,Phase 3,2008-06-01,"Sex: ALL; Age: >8 Years; Criteria: Inclusion Criteria:

* Age ³ 8 to \< 14 years (boys), ³ 8 to \< 12 years (girls)
* Student enrolled at participating school in classes 3-7
* Provision of informed consent from parent or guardian
* Pro...",Yes,2009-04-09,FDA-39332,2.62,0.32,5,7.94,2011-01-13,2011-05-10,2016-05-10,22,AstraZeneca,45,Kenya,47,82,87,2,34,52,25,55,1,3,2,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE
Artemether-lumefantrine (COA566),TradeName X,Drug,Malaria,Malaria,Phase 3,2014-07-01,"Sex: ALL; Criteria: Inclusion Criteria:

* Neonates / infants
* Body weight \< 5 kg
* In cohort 1, infants aged \> 28 days; in cohort 2, neonates of a term age 0 to ² 28 days
* Microscopically confirmed diagnosis of acut...",No,2015-01-09,FDA-30952,2.62,0.32,5,7.94,2017-02-11,2017-06-08,2022-06-09,7,AstraZeneca,87,Overall,48.33333333,38,95,88,12,42,15,82,1,4,4,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE
Hydroxyurea,Molecule Z,Drug,Malaria,Malaria,Phase 3,2017-11-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

* Pediatric subjects with documented sickle cell anemia (HbSS supported by hemoglobin electrophoresis or by peripheral blood smear showing sickled red blood cells)
* Age range of ...",No,2018-05-29,FDA-92542,2.62,0.32,5,7.94,2020-06-14,2020-10-09,2025-10-10,37,Sanofi,72,Overall,59.16666667,98,97,2,51,12,95,64,2,2,3,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE
Azithromycin plus chloroquine,GenName Y,Drug,Malaria,Malaria,Phase 3,2013-11-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

* Pregnant women (all gravidae) with ³14 and ²26 weeks of gestational age (by ultrasound).
* Evidence of a personally signed and dated informed consent/assent document. Assent wil...",Yes,2014-07-21,FDA-91151,2.62,0.32,5,7.94,2016-06-14,2016-10-09,2021-10-10,8,Pfizer,90,South Africa,48,16,36,40,61,72,63,45,1,3,1,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
ACT,Comp Beta,Drug,Malaria,Malaria,Phase 3,2020-03-04,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Male or female, aged from 2 years to 65 years old
* Acute uncomplicated P. falciparum malaria, confirmed by positive blood smear with asexual forms of P. falciparum (or mixed wi...",No,2020-06-19,FDA-15137,2.62,0.32,5,7.94,2022-10-16,2023-02-10,2028-02-11,86,Gilead,78,Overall,54.83333333,47,49,59,59,54,61,36,1,1,2,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE
Lamivudine,Product Alpha,Drug,Malaria,Malaria,Phase 3,2013-07-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Age \> 16 years (if \<18 years old, living independently from parents)
2. Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Western blot, ...",Yes,2013-12-27,FDA-60226,2.62,0.32,5,7.94,2016-02-12,2016-06-08,2021-06-09,5,Gilead,84,Senegal,30.5,46,34,9,4,16,74,45,1,3,1,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE
Zidovudine,Comp Beta,Drug,Malaria,Malaria,Phase 3,2013-07-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Age \> 16 years (if \<18 years old, living independently from parents)
2. Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Western blot, ...",Yes,2014-04-28,FDA-88082,2.62,0.32,5,7.94,2016-02-12,2016-06-08,2021-06-09,24,Gilead,51,Senegal,31.5,13,60,46,7,31,32,36,1,2,1,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
sulfadoxine-pyrimethamine (SP),Molecule Z,Drug,Malaria,Malaria,Phase 3,2014-04-01,"Sex: ALL; Age: >4 Months; Criteria: Inclusion Criteria:

1. Age 4 -5 months
2. Confirmed HIV status of biological mother
3. Negative HIV DNA PCR test at time of enrollment for infants born to HIV-infected mothers
4. Infants born to HIV-...",Yes,2014-05-21,FDA-21710,2.62,0.32,5,7.94,2016-11-12,2017-03-09,2022-03-10,77,Bayer,92,South Africa,66.66666667,96,21,68,92,97,26,45,2,3,0,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
ACT plus PQ (Rescue medication),AltName B,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2020-01-28,FDA-47535,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,26,Sanofi,47,Kenya,56.83333333,41,10,78,93,89,30,36,2,2,0,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE
PQ (End of study treatment),Molecule Z,Drug,Malaria,Malaria,Phase 3,2019-08-19,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria:

* Male subjects \>=18 years at the time of signing the informed consent.
* The subject has a positive Giemsa smear for P. vivax (mixed infection with P.falciparum is acceptable).
...",No,2020-06-11,FDA-19603,2.62,0.32,5,7.94,2022-04-01,2022-07-27,2027-07-28,25,J&J,5,Senegal,26,8,52,13,11,67,5,64,2,3,2,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE
Hypertonic saline,TradeName X,Drug,Malaria,Malaria,Phase 3,2023-12-31,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Peripheral P. falciparum parasitemia of any density
* Blantyre Coma Score ²2
* No evidence of meningitis on lumbar puncture
* Consciousness not regained after correction of hypo...",No,2024-05-01,FDA-85878,2.62,0.32,5,7.94,2026-08-13,2026-12-08,2031-12-09,39,Novartis,52,Kenya,64.33333333,26,30,57,97,85,91,64,1,4,2,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE
Tafenoquine Placebo,Product Alpha,Drug,Malaria,Malaria,Phase 3,2016-11-04,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria:

* A female is eligible to enter and participate in the study if she is non-pregnant, nonlactating and if she is of: a. Non-childbearing potential defined as: post-menopausal (12 m...",No,2017-09-26,FDA-68271,2.62,0.32,5,7.94,2019-06-18,2019-10-13,2024-10-13,59,Pfizer,6,Kenya,39.66666667,23,0,59,33,58,65,45,1,3,1,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE
Primaquine Placebo,AltName B,Drug,Malaria,Malaria,Phase 3,2016-11-04,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria:

* A female is eligible to enter and participate in the study if she is non-pregnant, nonlactating and if she is of: a. Non-childbearing potential defined as: post-menopausal (12 m...",Yes,2017-03-29,FDA-54664,2.62,0.32,5,7.94,2019-06-18,2019-10-13,2024-10-13,66,Novartis,79,South Africa,49.5,22,69,39,37,37,93,55,2,2,2,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE
Efavirenz,Comp Beta,Drug,Malaria,Malaria,Phase 3,2013-07-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Age \> 16 years (if \<18 years old, living independently from parents)
2. Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Western blot, ...",No,2014-04-23,FDA-58574,2.62,0.32,5,7.94,2016-02-12,2016-06-08,2021-06-09,90,GSK,68,Senegal,30,77,4,12,5,64,18,64,2,3,2,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE
Azithromycin plus Chloroquine,AltName A,Drug,Malaria,Malaria,Phase 3,2010-09-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Girls and boys ³5 years to ²12 years (Cohort 1); and ³6 to ²59 months of age (Cohort 2) with uncomplicated, symptomatic malaria as indicated by the presence of the following:
* ...",Yes,2011-08-18,FDA-30392,2.62,0.32,5,7.94,2013-04-14,2013-08-09,2018-08-10,30,Pfizer,60,South Africa,47.16666667,96,90,1,28,59,9,45,1,2,2,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE
Mefloquine plus artesunate,TradeName X,Drug,Malaria,Malaria,Phase 3,2008-12-01,"Sex: ALL; Age: >3 Years; Criteria: Inclusion Criteria:

* Male or female patients between the ages of 3 and 60 years, inclusive.
* Body weight between 20 kg and 90 kg with no clinical evidence of severe malnutrition.
* Presence of acut...",No,2009-04-19,FDA-63859,2.62,0.32,5,7.94,2011-07-15,2011-11-09,2016-11-09,72,Novartis,72,Kenya,65.16666667,30,80,84,71,59,67,45,0,2,3,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE
1. Artemether-Lumefantrine (AL),GenName Y,Drug,Malaria,Malaria,Phase 3,2009-07-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion criteria:

* children aged 6-120 months;
* axillary temperature ³ 37.5¡C and/or history of fever within past 24 hours;
* P. falciparum asexual parasitemia between 1000 and 100000/µl;
* abili...",No,2010-02-06,FDA-63639,2.62,0.32,5,7.94,2012-02-12,2012-06-08,2017-06-09,3,Merck,73,Kenya,30.33333333,60,22,31,33,22,14,18,1,1,0,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE
2. Amodiaquine-Artesunate (AQ-AS),AltName B,Drug,Malaria,Malaria,Phase 3,2009-07-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion criteria:

* children aged 6-120 months;
* axillary temperature ³ 37.5¡C and/or history of fever within past 24 hours;
* P. falciparum asexual parasitemia between 1000 and 100000/µl;
* abili...",No,2009-08-28,FDA-68265,2.62,0.32,5,7.94,2012-02-12,2012-06-08,2017-06-09,34,Pfizer,64,South Africa,32,1,41,28,41,76,5,64,0,5,2,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
Lopinavir/ritonavir,Product Alpha,Drug,Malaria,Malaria,Phase 3,2013-07-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Age \> 16 years (if \<18 years old, living independently from parents)
2. Documentation of HIV status must come from two assays. Assays include DNA PCR, HIV RNA, Western blot, ...",No,2013-10-10,FDA-91977,2.62,0.32,5,7.94,2016-02-12,2016-06-08,2021-06-09,1,GSK,62,South Africa,37.66666667,59,9,59,29,50,20,45,1,2,2,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
dihydroartemisinin-piperaquine (DP),Product Alpha,Drug,Malaria,Malaria,Phase 3,2014-04-01,"Sex: ALL; Age: >4 Months; Criteria: Inclusion Criteria:

1. Age 4 -5 months
2. Confirmed HIV status of biological mother
3. Negative HIV DNA PCR test at time of enrollment for infants born to HIV-infected mothers
4. Infants born to HIV-...",No,2014-06-28,FDA-88856,2.62,0.32,5,7.94,2016-11-12,2017-03-09,2022-03-10,40,Bayer,11,South Africa,60.83333333,66,51,27,97,49,75,55,1,3,2,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE
trimethoprim-sulfamethoxazole (TS; TMP/SMX),Molecule Z,Drug,Malaria,Malaria,Phase 3,2014-04-01,"Sex: ALL; Age: >4 Months; Criteria: Inclusion Criteria:

1. Age 4 -5 months
2. Confirmed HIV status of biological mother
3. Negative HIV DNA PCR test at time of enrollment for infants born to HIV-infected mothers
4. Infants born to HIV-...",Yes,2015-01-30,FDA-18462,2.62,0.32,5,7.94,2016-11-12,2017-03-09,2022-03-10,89,Bayer,0,South Africa,22.66666667,31,8,30,0,13,54,64,1,3,3,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE
3 dose dihydroartemisinin-piperaquine (DP) for adult women during pregnancy,Molecule Z,Drug,Malaria,Malaria,Phase 3,2018-05-14,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV uninfected ...",Yes,2018-06-14,FDA-60623,2.62,0.32,5,7.94,2020-12-25,2021-04-21,2026-04-22,98,GSK,92,Overall,55,97,73,38,26,91,5,45,1,3,1,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);",GenName Y,Biological,Malaria,Malaria,Phase 3,2013-05-24,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant or child between and including 6 weeks to 17 months of age, at the time of first va...",No,2013-09-09,FDA-67084,2.62,0.32,5,7.94,2016-01-05,2016-05-01,2021-05-02,18,Sanofi,73,Overall,35.16666667,15,42,38,81,1,34,55,2,3,1,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE
Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine (Rabipur or equivalent) (Novartis).,TradeName X,Biological,Malaria,Malaria,Phase 3,2013-05-24,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant or child between and including 6 weeks to 17 months of age, at the time of first va...",No,2014-01-28,FDA-90245,2.62,0.32,5,7.94,2016-01-05,2016-05-01,2021-05-02,33,Novartis,1,Kenya,57.83333333,25,17,60,86,72,87,55,1,3,2,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049),Product Alpha,Biological,Malaria,Malaria,Phase 3,2012-05-04,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* Subjects who the investigator believes that their parent(s)/Legally Acceptable Representative(s) (LAR) can and will comply with the requirements of the protocol.
* A male or fem...",No,2012-10-13,FDA-86252,2.62,0.32,5,7.94,2014-12-16,2015-04-12,2020-04-12,79,J&J,75,Senegal,59,8,78,66,85,61,56,73,0,5,3,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE
Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy,Comp Beta,Drug,Malaria,Malaria,Phase 3,2018-12-04,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

* Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
* Estimated gestational age between 12-20 weeks
* Confirmed to be HIV uninfected by ...",No,2019-03-12,FDA-49165,2.62,0.32,5,7.94,2021-07-17,2021-11-11,2026-11-12,62,GSK,70,Kenya,60.33333333,31,37,96,67,44,87,36,0,3,1,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE
Artesunate,Molecule Z,Drug,Malaria,Malaria,Phase 3,2012-09-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Subjects aged greater than or equal to 6 months to 5 years presenting to Ndirande Health Centre with signs or symptoms consistent with malaria including, but not limited to, one...",No,2013-05-12,FDA-83742,2.62,0.32,5,7.94,2015-04-15,2015-08-10,2020-08-10,50,Gilead,89,Senegal,32.66666667,20,39,25,15,57,40,55,0,4,2,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE
GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049,TradeName X,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",Yes,2017-06-15,FDA-59597,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,71,AstraZeneca,38,South Africa,46.66666667,90,60,56,29,36,9,55,0,4,2,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE
Engerix-Bª vaccine,GenName Y,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",No,2018-02-08,FDA-55053,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,57,Sanofi,93,Overall,61.5,81,52,73,43,41,79,45,0,3,2,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE
Infanrix/Hibª vaccine,Product Alpha,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",Yes,2017-06-28,FDA-79141,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,95,Merck,95,Kenya,35.66666667,29,35,26,35,3,86,64,2,3,2,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE
Polio Sabinª vaccine,TradeName X,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",No,2017-07-10,FDA-22671,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,20,Bayer,27,Senegal,58.5,69,88,38,24,82,50,55,1,3,2,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
Rotarixª vaccine,AltName B,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",No,2017-05-09,FDA-86276,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,38,Pfizer,15,Senegal,43.33333333,5,21,78,88,1,67,45,1,2,2,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
Synflorixª vaccine,Comp Beta,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",No,2017-10-16,FDA-17826,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,1,Bayer,99,Kenya,34.5,9,28,55,17,86,12,55,2,3,1,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
Measles vaccine,Product Alpha,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",Yes,2017-09-19,FDA-11426,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,19,J&J,8,Kenya,48.5,81,49,22,18,36,85,36,1,2,1,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
Yellow fever vaccine,TradeName X,Biological,Malaria,Malaria,Phase 3,2017-02-09,"Sex: ALL; Age: >8 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant aged between 8 and 12 weeks inclusive at the time of first vaccination
* Signed or ...",Yes,2017-04-13,FDA-53500,2.62,0.32,5,7.94,2019-09-23,2020-01-18,2025-01-18,9,AstraZeneca,36,Senegal,53.5,62,72,39,73,33,42,91,1,5,4,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE
GSK Biological's Investigational Malaria Vaccine 257049,AltName B,Biological,Malaria,Malaria,Phase 3,2013-05-24,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy ALL the following criteria at study entry:

* A male or female infant or child between and including 6 weeks to 17 months of age, at the time of first va...",Yes,2013-09-09,FDA-94435,2.62,0.32,5,7.94,2016-01-05,2016-05-01,2021-05-02,100,Merck,29,Senegal,46.5,53,26,95,10,2,93,73,2,4,2,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE
Placebo oral tablet,Molecule Z,Drug,Malaria,Malaria,Phase 3,2024-08-01,"Sex: ALL; Criteria: Inclusion Criteria (for being enrolled in the study):

* Residence in selected study village
* Able to understand the information and willing to give consent or assent (age 12-18) and parent/guardian ...",Yes,2025-07-09,FDA-30551,2.62,0.32,5,7.94,2027-03-15,2027-07-10,2032-07-10,22,J&J,71,Overall,57,69,17,52,60,61,83,55,2,2,2,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE
Sulfadoxine-pyrimethamine,Comp Beta,Drug,Malaria,Malaria,Phase 3,2015-01-01,"Sex: FEMALE; Criteria: Inclusion Criteria:

Women who present to the Ndirande Antenatal Clinic (ANC) and meet the following inclusion criteria will be enrolled in the study: -Before the end of 27th week of gestation -First ...",Yes,2015-09-19,FDA-24425,2.62,0.32,5,7.94,2017-08-14,2017-12-09,2022-12-10,41,GSK,27,Kenya,66,24,86,96,76,47,67,27,0,2,1,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
Malaria Vaccine 257049 (MALARIA-055 PRI),AltName A,Biological,Malaria,Malaria,Phase 3,2017-01-31,"Sex: ALL; Age: >42 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who ...",No,2017-07-24,FDA-21618,2.62,0.32,5,7.94,2019-09-14,2020-01-09,2025-01-09,83,Sanofi,75,Kenya,30.5,28,43,71,31,2,8,45,1,2,2,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE
Meningococcal C Conjugate Vaccine (MALARIA-055 PRI),Product Alpha,Biological,Malaria,Malaria,Phase 3,2017-01-31,"Sex: ALL; Age: >42 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who ...",Yes,2017-10-30,FDA-11988,2.62,0.32,5,7.94,2019-09-14,2020-01-09,2025-01-09,80,Sanofi,36,South Africa,41.83333333,2,76,72,36,15,50,55,2,2,2,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
Cell-culture rabies vaccine (MALARIA-055 PRI),AltName A,Biological,Malaria,Malaria,Phase 3,2017-01-31,"Sex: ALL; Age: >42 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who ...",No,2017-04-21,FDA-91910,2.62,0.32,5,7.94,2019-09-14,2020-01-09,2025-01-09,91,Bayer,60,Kenya,33.5,25,5,68,66,13,24,55,1,2,3,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE
TritanrixHepB/Hib (MALARIA-055 PRI),AltName B,Biological,Malaria,Malaria,Phase 3,2017-01-31,"Sex: ALL; Age: >42 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who ...",Yes,2017-09-15,FDA-36803,2.62,0.32,5,7.94,2019-09-14,2020-01-09,2025-01-09,66,GSK,62,Kenya,69.83333333,64,36,75,82,78,84,64,1,4,2,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE
Polio Sabin Oral Polio Vaccine (GSK) (MALARIA-055 PRI),Molecule Z,Biological,Malaria,Malaria,Phase 3,2017-01-31,"Sex: ALL; Age: >42 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who ...",No,2017-05-20,FDA-63276,2.62,0.32,5,7.94,2019-09-14,2020-01-09,2025-01-09,16,Gilead,96,Senegal,34.83333333,7,19,29,57,7,90,64,2,3,2,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE
Candidate Plasmodium falciparum malaria vaccine,AltName B,Biological,Malaria,Malaria,Phase 3,2020-10-07,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/Legally Acceptable Representative(s) (LAR\[s\]) who, in the opinion of the investigator, could and complied with the requirements of the protocol.
* A male o...",No,2020-12-01,FDA-72599,2.62,0.32,5,7.94,2023-05-21,2023-09-15,2028-09-15,42,Novartis,91,South Africa,26.5,64,20,9,23,28,15,73,1,3,4,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE
Polio Sabin Oral Polio Vaccine (GSK),Molecule Z,Biological,Malaria,Malaria,Phase 3,2014-01-31,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female child of:5-17 months (inclusive) of age at time of first vaccination,or between 6-12 weeks of ...",Yes,2014-11-04,FDA-89470,2.62,0.32,5,7.94,2016-09-13,2017-01-08,2022-01-09,68,Gilead,73,South Africa,35.5,6,36,60,5,29,77,64,2,3,2,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE
MR-Vac,Molecule Z,Biological,Malaria,Malaria,Phase 3,2020-10-07,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/Legally Acceptable Representative(s) (LAR\[s\]) who, in the opinion of the investigator, could and complied with the requirements of the protocol.
* A male o...",No,2021-01-26,FDA-29398,2.62,0.32,5,7.94,2023-05-21,2023-09-15,2028-09-15,90,Bayer,15,South Africa,55,38,64,89,40,34,65,27,1,0,2,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE
Stamaril,AltName A,Biological,Malaria,Malaria,Phase 3,2020-10-07,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Subjects' parent(s)/Legally Acceptable Representative(s) (LAR\[s\]) who, in the opinion of the investigator, could and complied with the requirements of the protocol.
* A male o...",No,2021-09-12,FDA-27784,2.62,0.32,5,7.94,2023-05-21,2023-09-15,2028-09-15,59,Bayer,76,Overall,64.66666667,84,42,15,90,72,85,45,2,2,1,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
Malaria Vaccine 257049,Molecule Z,Biological,Malaria,Malaria,Phase 3,2014-01-31,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female child of:5-17 months (inclusive) of age at time of first vaccination,or between 6-12 weeks of ...",No,2014-07-03,FDA-10012,2.62,0.32,5,7.94,2016-09-13,2017-01-08,2022-01-09,55,Sanofi,83,Overall,70.83333333,86,96,54,25,73,91,27,0,1,2,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
Meningococcal C Conjugate Vaccine,Product Alpha,Biological,Malaria,Malaria,Phase 3,2014-01-31,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female child of:5-17 months (inclusive) of age at time of first vaccination,or between 6-12 weeks of ...",Yes,2014-07-04,FDA-85207,2.62,0.32,5,7.94,2016-09-13,2017-01-08,2022-01-09,10,Merck,68,Senegal,71,95,90,70,46,28,97,55,1,3,2,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE
Cell-culture rabies vaccine,AltName B,Biological,Malaria,Malaria,Phase 3,2014-01-31,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female child of:5-17 months (inclusive) of age at time of first vaccination,or between 6-12 weeks of ...",No,2015-01-14,FDA-81897,2.62,0.32,5,7.94,2016-09-13,2017-01-08,2022-01-09,99,Merck,51,Senegal,38.83333333,11,33,25,64,2,98,36,0,3,1,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE
TritanrixHepB/Hib,AltName A,Biological,Malaria,Malaria,Phase 3,2014-01-31,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female child of:5-17 months (inclusive) of age at time of first vaccination,or between 6-12 weeks of ...",No,2014-11-29,FDA-40155,2.62,0.32,5,7.94,2016-09-13,2017-01-08,2022-01-09,16,Novartis,43,Overall,41.83333333,27,35,54,49,75,11,55,1,3,2,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy,AltName B,Drug,Malaria,Malaria,Phase 3,2018-05-14,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV uninfected ...",No,2019-02-15,FDA-27655,2.62,0.32,5,7.94,2020-12-25,2021-04-21,2026-04-22,95,Novartis,8,Kenya,40.5,43,16,54,13,58,59,27,0,2,1,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE
Monthly dihydroartemisinin-piperaquine (DP) for infants,TradeName X,Drug,Malaria,Malaria,Phase 3,2018-05-14,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV uninfected ...",Yes,2018-07-20,FDA-51444,2.62,0.32,5,7.94,2020-12-25,2021-04-21,2026-04-22,1,Merck,13,South Africa,47.5,9,40,52,40,76,68,55,1,4,1,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE
Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy,GenName Y,Drug,Malaria,Malaria,Phase 3,2018-12-04,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

* Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
* Estimated gestational age between 12-20 weeks
* Confirmed to be HIV uninfected by ...",Yes,2019-07-24,FDA-40410,2.62,0.32,5,7.94,2021-07-17,2021-11-11,2026-11-12,5,Merck,88,Senegal,72.16666667,98,37,32,85,81,100,73,2,4,2,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE
3 dose sulfadoxine-pyrimethamine (SP) for adult women during pregnancy,Comp Beta,Drug,Malaria,Malaria,Phase 3,2018-05-14,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV uninfected ...",No,2018-06-21,FDA-28230,2.62,0.32,5,7.94,2020-12-25,2021-04-21,2026-04-22,51,Sanofi,54,South Africa,42.33333333,26,14,47,32,41,94,55,2,2,2,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE
3-monthly dihydroartemisinin-piperaquine (DP) for infants,Comp Beta,Drug,Malaria,Malaria,Phase 3,2018-05-14,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

1. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound
2. Estimated gestational age between 12-20 weeks
3. Confirmed to be HIV uninfected ...",No,2019-01-25,FDA-29994,2.62,0.32,5,7.94,2020-12-25,2021-04-21,2026-04-22,85,J&J,12,South Africa,55,61,32,41,83,67,46,55,2,3,1,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE
Rouvaxª,Comp Beta,Biological,Malaria,Malaria,Phase 2,2009-10-07,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Signed or thumb-printed informed consent obtained from the parent(s)/guardian(s) of the...",Yes,2010-04-11,FDA-69631,4.41,0.98,21,26.39,2014-03-05,2015-02-26,2036-02-26,99,AstraZeneca,30,Senegal,58,36,48,81,48,78,57,55,0,2,4,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE
KAF156,GenName Y,Drug,Malaria,Malaria,Phase 2,2021-06-28,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Part A: male and female patients ³ 12 years and with a body weight ³ 35.0 kg. Part B: after determining the effective/tolerated doses and regimens in adolescent and adult patien...",No,2022-02-22,FDA-81356,4.41,0.98,21,26.39,2025-11-24,2026-11-17,2047-11-17,26,Gilead,55,Senegal,67.66666667,75,71,70,46,93,51,27,1,1,1,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE
"RTS, S/AS01B",AltName A,Biological,Malaria,Malaria,Phase 2,2006-09-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion criteria:

* Healthy male or female volunteers aged between 18 and 35 years at the time of first vaccination who have given written consent for their participation in the study were included...",No,2007-07-13,FDA-44674,4.41,0.98,21,26.39,2011-01-28,2012-01-21,2033-01-20,92,Novartis,68,Kenya,40.33333333,17,98,15,38,72,2,45,2,0,3,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE
Prevnarª,Comp Beta,Biological,Malaria,Malaria,Phase 2,2007-05-01,"Sex: ALL; Age: >33 Months; Criteria: Inclusion criteria:

* Completion of Visit 7, Month 21 of 104297 (NCT= NCT00197041).
* Written informed consent obtained from the parent(s) or guardian(s) of the subject

Exclusion criteria:

* Planne...",No,2008-03-04,FDA-28003,4.41,0.98,21,26.39,2011-09-27,2012-09-19,2033-09-19,27,Gilead,99,Kenya,34.33333333,55,18,92,21,18,2,55,0,3,3,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE
Hiberix¨,GenName Y,Biological,Malaria,Malaria,Phase 2,2007-05-01,"Sex: ALL; Age: >33 Months; Criteria: Inclusion criteria:

* Completion of Visit 7, Month 21 of 104297 (NCT= NCT00197041).
* Written informed consent obtained from the parent(s) or guardian(s) of the subject

Exclusion criteria:

* Planne...",No,2007-10-04,FDA-29415,4.41,0.98,21,26.39,2011-09-27,2012-09-19,2033-09-19,67,GSK,65,Overall,58.83333333,63,23,69,67,77,54,73,1,3,4,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE
Engerixª-B,Molecule Z,Biological,Malaria,Malaria,Phase 2,2007-05-01,"Sex: ALL; Age: >33 Months; Criteria: Inclusion criteria:

* Completion of Visit 7, Month 21 of 104297 (NCT= NCT00197041).
* Written informed consent obtained from the parent(s) or guardian(s) of the subject

Exclusion criteria:

* Planne...",No,2008-04-09,FDA-76465,4.41,0.98,21,26.39,2011-09-27,2012-09-19,2033-09-19,10,Sanofi,34,South Africa,43.5,17,16,38,68,68,54,55,2,2,2,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049,AltName B,Biological,Malaria,Malaria,Phase 2,2007-05-01,"Sex: ALL; Age: >33 Months; Criteria: Inclusion criteria:

* Completion of Visit 7, Month 21 of 104297 (NCT= NCT00197041).
* Written informed consent obtained from the parent(s) or guardian(s) of the subject

Exclusion criteria:

* Planne...",Yes,2007-06-10,FDA-74356,4.41,0.98,21,26.39,2011-09-27,2012-09-19,2033-09-19,39,J&J,69,Overall,25.66666667,11,25,14,60,37,7,55,0,3,3,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE
Lumefantrine Solid Dispersion Formulation,Molecule Z,Drug,Malaria,Malaria,Phase 2,2021-06-28,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Part A: male and female patients ³ 12 years and with a body weight ³ 35.0 kg. Part B: after determining the effective/tolerated doses and regimens in adolescent and adult patien...",No,2021-12-22,FDA-89543,4.41,0.98,21,26.39,2025-11-24,2026-11-17,2047-11-17,74,Sanofi,23,South Africa,45.16666667,16,18,98,26,57,56,64,0,3,4,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
Coartem,TradeName X,Drug,Malaria,Malaria,Phase 2,2021-06-28,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Part A: male and female patients ³ 12 years and with a body weight ³ 35.0 kg. Part B: after determining the effective/tolerated doses and regimens in adolescent and adult patien...",Yes,2021-12-13,FDA-54064,4.41,0.98,21,26.39,2025-11-24,2026-11-17,2047-11-17,96,Merck,57,Overall,40.5,45,48,73,8,58,11,64,1,3,3,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
Rabipur (Rabies) Vaccine,GenName Y,Biological,Malaria,Malaria,Phase 2,2006-09-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion criteria:

* Healthy male or female volunteers aged between 18 and 35 years at the time of first vaccination who have given written consent for their participation in the study were included...",No,2006-11-19,FDA-55951,4.41,0.98,21,26.39,2011-01-28,2012-01-21,2033-01-20,99,Pfizer,48,Overall,68.83333333,55,91,55,80,66,66,45,0,2,3,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE
Artemether,Molecule Z,Drug,Malaria,Malaria,Phase 2,2010-01-01,"Sex: ALL; Criteria: Inclusion Criteria:

1. The patient's parent or attendant relative has provided informed consent and the patient has assented (where relevant) to participation in the trial
2. The patient is a child t...",Yes,2010-11-28,FDA-75095,4.41,0.98,21,26.39,2014-05-30,2015-05-23,2036-05-22,50,AstraZeneca,16,Senegal,58.66666667,79,8,79,61,94,31,36,1,1,2,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
VMP001,AltName B,Biological,Malaria,Malaria,Phase 2,2012-01-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who meet all of the following criteria may participate in this study:
* Healthy adults (male or non-pregnant, non-lactating female) 18 to 55 years of age (inclusive) at...",Yes,2012-12-22,FDA-44860,4.41,0.98,21,26.39,2016-05-29,2017-05-22,2038-05-22,15,Pfizer,10,South Africa,47.16666667,28,15,87,60,87,6,64,1,3,3,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE
GSK Biologicals' malaria vaccine 257049 (3 doses),AltName A,Biological,Malaria,Malaria,Phase 2,2012-07-03,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who the investigator believes can and will comply with the requirements of the protocol.
* A male or non-pregnant female 18 to 50 years of age at the time of first vacc...",Yes,2013-02-25,FDA-78416,4.41,0.98,21,26.39,2016-11-29,2017-11-22,2038-11-22,30,Pfizer,55,Kenya,43.33333333,5,100,8,76,71,0,36,0,1,3,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE
GSK Biologicals' malaria vaccine 257049 (2 doses),Molecule Z,Biological,Malaria,Malaria,Phase 2,2012-07-03,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who the investigator believes can and will comply with the requirements of the protocol.
* A male or non-pregnant female 18 to 50 years of age at the time of first vacc...",Yes,2013-01-25,FDA-68055,4.41,0.98,21,26.39,2016-11-29,2017-11-22,2038-11-22,30,J&J,15,South Africa,71.5,82,47,91,46,95,68,73,2,3,3,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE
Crucell's replication deficient adenovirus type 35 circumsporozoite malaria vaccine (Ad35.CS.01),Product Alpha,Biological,Malaria,Malaria,Phase 2,2012-07-03,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who the investigator believes can and will comply with the requirements of the protocol.
* A male or non-pregnant female 18 to 50 years of age at the time of first vacc...",Yes,2012-09-02,FDA-55829,4.41,0.98,21,26.39,2016-11-29,2017-11-22,2038-11-22,18,Bayer,51,Senegal,39.66666667,13,61,10,31,23,100,64,2,4,1,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE
"RTS,S/AS01E (SB257049)",Comp Beta,Biological,Malaria,Malaria,Phase 2,2019-09-26,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

Only for subjects from MALARIA-092 study (NCT03162614):

¥ Subjects vaccinated and having undergone sporozoite challenge during the primary study (MALARIA-092 \[NCT03162614\]).

F...",No,2020-03-04,FDA-95929,4.41,0.98,21,26.39,2024-02-22,2025-02-14,2046-02-14,42,AstraZeneca,39,Senegal,37.83333333,25,93,3,4,88,14,73,1,3,4,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
"RTS, S/AS02A",Product Alpha,Biological,Malaria,Malaria,Phase 2,2006-09-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion criteria:

* Healthy male or female volunteers aged between 18 and 35 years at the time of first vaccination who have given written consent for their participation in the study were included...",Yes,2006-10-20,FDA-48780,4.41,0.98,21,26.39,2011-01-28,2012-01-21,2033-01-20,20,Pfizer,6,Overall,48.33333333,67,32,52,60,48,31,55,0,2,4,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE
ChAd63 PvDBP and MVA PvDBP,GenName Y,Biological,Malaria,Malaria,Phase 2,2022-07-07,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Healthy adult aged 18 to 45 years.
* Red blood cells positive for the Duffy antigen/chemokine receptor (DARC).
* Normal serum levels of Glucose-6-phosphate dehydrogenase (G6PD)....",Yes,2023-04-09,FDA-48070,4.41,0.98,21,26.39,2026-12-03,2027-11-26,2048-11-25,75,J&J,45,Senegal,59.66666667,56,75,42,77,37,71,45,1,2,2,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
"Double RTS,S/AS01E Fractional dose",Molecule Z,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",No,2019-01-03,FDA-98917,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,13,Sanofi,98,Kenya,61.5,22,25,71,97,61,93,45,1,3,1,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE
Primaquine 15mg (Part2 ),Comp Beta,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",No,2017-01-08,FDA-45218,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,4,J&J,46,Overall,48.5,53,57,35,22,34,90,64,1,3,3,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE
Methylene Blue,Molecule Z,Drug,Malaria,Malaria,Phase 2,2017-02-01,"Sex: ALL; Age: >6 Months; Criteria: Inclusion Criteria:

* Weight ³ 6 kg
* Uncomplicated malaria caused by P. falciparum
* Asexual parasites ³ 2 000/µl and ² 100 000/µl
* Axillary temperature ³ 37.5¡C or a history of fever during the la...",No,2017-03-31,FDA-19658,4.41,0.98,21,26.39,2021-06-30,2022-06-23,2043-06-23,27,Gilead,29,South Africa,50.16666667,29,12,49,87,89,35,73,1,4,3,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE
PfSPZ Vaccine,Comp Beta,Biological,Malaria,Malaria,Phase 2,2023-03-17,"Sex: ALL; Criteria: * INCLUSION CRITERIA:

  1. Females of child bearing potential aged greater than or equal to 18 and less than or equal to 38 years
  2. Able to provide proof of identity to the satisfaction of the stu...",No,2024-01-12,FDA-32088,4.41,0.98,21,26.39,2027-08-13,2028-08-05,2049-08-05,76,Sanofi,39,Kenya,58,80,13,75,89,6,85,55,1,3,2,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE
amodiaquine,TradeName X,Drug,Malaria,Malaria,Phase 2,2007-05-01,"Sex: ALL; Age: >33 Months; Criteria: Inclusion criteria:

* Completion of Visit 7, Month 21 of 104297 (NCT= NCT00197041).
* Written informed consent obtained from the parent(s) or guardian(s) of the subject

Exclusion criteria:

* Planne...",Yes,2007-11-04,FDA-67285,4.41,0.98,21,26.39,2011-09-27,2012-09-19,2033-09-19,60,Merck,42,South Africa,44.83333333,12,23,54,57,40,83,36,1,2,1,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE
R21/Matrix-M vaccination,AltName B,Biological,Malaria,Malaria,Phase 2,2023-09-18,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria

The participant is eligible to enter the study if all of the following apply:

1. Participant is a healthy adult, aged 18 to 55 years (inclusive), of Thai origin.
2. Participant is...",No,2023-11-14,FDA-13188,4.41,0.98,21,26.39,2028-02-14,2029-02-06,2050-02-06,26,Bayer,3,South Africa,63.66666667,89,23,85,57,62,66,91,2,5,3,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE
DHA-PIP,AltName A,Drug,Malaria,Malaria,Phase 2,2023-09-18,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria

The participant is eligible to enter the study if all of the following apply:

1. Participant is a healthy adult, aged 18 to 55 years (inclusive), of Thai origin.
2. Participant is...",No,2024-09-09,FDA-60865,4.41,0.98,21,26.39,2028-02-14,2029-02-06,2050-02-06,55,GSK,18,South Africa,34.16666667,31,2,23,58,41,50,45,1,2,2,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
PQ,TradeName X,Drug,Malaria,Malaria,Phase 2,2023-09-18,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria

The participant is eligible to enter the study if all of the following apply:

1. Participant is a healthy adult, aged 18 to 55 years (inclusive), of Thai origin.
2. Participant is...",No,2024-08-04,FDA-19305,4.41,0.98,21,26.39,2028-02-14,2029-02-06,2050-02-06,40,Gilead,20,Senegal,51.33333333,71,26,0,73,54,84,45,1,1,3,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE
Chloroquine 600mg,Comp Beta,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",No,2017-02-23,FDA-41569,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,18,Gilead,51,Senegal,45,38,20,85,41,53,33,45,1,2,2,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE
Chloroquine 300mg,AltName B,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",No,2017-10-10,FDA-76288,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,94,GSK,60,Overall,74.66666667,61,33,95,73,86,100,55,0,3,3,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE
Tafenoquine 50mg,Molecule Z,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-06-30,FDA-13328,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,97,GSK,48,Kenya,63.33333333,35,94,41,67,63,80,45,0,3,2,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
Tafenoquine 100mg,TradeName X,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-10-27,FDA-70892,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,87,J&J,77,Kenya,67.5,69,87,82,65,70,32,55,0,4,2,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE
Tafenoquine 300mg,TradeName X,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-07-29,FDA-93499,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,22,Novartis,5,South Africa,72,100,73,68,83,63,45,55,1,2,3,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE
Tafenoquine 600mg,GenName Y,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",No,2017-05-10,FDA-85222,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,22,AstraZeneca,54,Kenya,32.66666667,17,85,44,44,4,2,36,0,3,1,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE
Primaquine 15mg,AltName B,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-07-06,FDA-77326,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,0,Merck,21,Overall,50.83333333,26,53,34,65,72,55,45,1,3,1,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
Chloroquine 600mg (Part 2 ),GenName Y,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-01-26,FDA-28347,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,28,Novartis,76,South Africa,36.33333333,39,65,30,29,11,44,55,1,3,2,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE
Chloroquine 300mg (Part 2 ),AltName A,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",No,2016-12-31,FDA-58007,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,44,GSK,2,South Africa,43,12,63,39,47,97,0,45,1,3,1,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE
Tafenoquine 300mg (Part 2),Molecule Z,Drug,Malaria,Malaria,Phase 2,2016-11-18,"Sex: ALL; Age: >16 Years; Criteria: Inclusion Criteria: - Positive Giemsa smear for P. vivax

* Parasite density \>100 and \<200,000/_L
* ³16 years
* A female is eligible if she is non-pregnant, nonlactating and if she is of: - non-chil...",Yes,2017-01-23,FDA-18350,4.41,0.98,21,26.39,2021-04-16,2022-04-09,2043-04-09,66,Sanofi,7,Senegal,38.66666667,38,89,8,5,92,0,64,0,5,2,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE
"RTS,S/AS01B Fractional dose",Comp Beta,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",Yes,2018-10-05,FDA-21456,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,100,Sanofi,30,South Africa,54.83333333,46,34,39,85,93,32,64,0,5,2,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE
"RTS,S/AS01E + DHA-PIP+PQ Standard dose",GenName Y,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",Yes,2018-09-14,FDA-31092,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,1,Merck,88,Senegal,36.83333333,37,24,17,12,31,100,45,1,3,1,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE
"RTS,S/AS01E Standard dose",Product Alpha,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",No,2018-05-01,FDA-16153,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,55,Merck,13,Overall,53.83333333,59,26,84,48,51,55,55,1,3,2,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
KAE609,Product Alpha,Drug,Malaria,Malaria,Phase 2,2014-08-01,"Sex: ALL; Age: >20 Years; Criteria: Inclusion Criteria:

* Male and female patients aged 20 to 60 years
* Presence of mono-infection of P. falciparum
* Weight between 40 kg to 90 kg

Exclusion Criteria:

* Patients with signs and sympto...",No,2014-11-07,FDA-81210,4.41,0.98,21,26.39,2018-12-28,2019-12-21,2040-12-20,97,Sanofi,60,Overall,57.66666667,83,50,81,22,52,58,55,1,3,2,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
"NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA",AltName B,Biological,Malaria,Malaria,Phase 2,2017-09-25,"Sex: ALL; Age: >18 Years; Criteria: INCLUSION CRITERIA:

* Between the ages of 18-50 (inclusive)
* Negative results of HIV ELISA, HbSAg, anti-HCV antibody, and no other clinically significant abnormal laboratory results from screening.
...",Yes,2018-02-21,FDA-75925,4.41,0.98,21,26.39,2022-02-21,2023-02-14,2044-02-14,22,Pfizer,76,South Africa,23.66666667,62,4,0,49,7,20,45,1,2,2,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE
Emtricitabine/tenofovir disoproxil fumarate,Molecule Z,Drug,Malaria,Malaria,Phase 2,2016-06-19,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* HIV-1 infection
* CD4+ count \> 200 and \< 500 cells/mm\^3 obtained within 30 days prior to study entry at a DAIDS-approved laboratory.
* Pf SCP confirmed in a laboratory approv...",No,2017-02-18,FDA-25269,4.41,0.98,21,26.39,2020-11-15,2021-11-08,2042-11-08,81,AstraZeneca,32,South Africa,54.83333333,70,74,31,87,21,46,64,2,3,2,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE
Nevirapine,Comp Beta,Drug,Malaria,Malaria,Phase 2,2016-06-19,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* HIV-1 infection
* CD4+ count \> 200 and \< 500 cells/mm\^3 obtained within 30 days prior to study entry at a DAIDS-approved laboratory.
* Pf SCP confirmed in a laboratory approv...",Yes,2017-01-29,FDA-80731,4.41,0.98,21,26.39,2020-11-15,2021-11-08,2042-11-08,36,GSK,48,South Africa,50.16666667,76,75,20,40,48,42,45,1,4,0,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
Trimethoprim/sulfamethoxazole,TradeName X,Drug,Malaria,Malaria,Phase 2,2016-06-19,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* HIV-1 infection
* CD4+ count \> 200 and \< 500 cells/mm\^3 obtained within 30 days prior to study entry at a DAIDS-approved laboratory.
* Pf SCP confirmed in a laboratory approv...",No,2016-07-23,FDA-34327,4.41,0.98,21,26.39,2020-11-15,2021-11-08,2042-11-08,12,Pfizer,1,Kenya,41.5,100,16,37,10,53,33,36,0,2,2,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE
RH5.1/ ASO1,Product Alpha,Biological,Malaria,Malaria,Phase 2,2019-06-27,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Healthy adults aged 18 to 45 years.
* Able and willing (in the Investigator's opinion) to comply with all study requirements.
* Willing to allow the Investigators to discuss the...",Yes,2019-09-16,FDA-41813,4.41,0.98,21,26.39,2023-11-23,2024-11-15,2045-11-15,98,Merck,99,Overall,37.83333333,43,45,99,21,8,11,18,0,1,1,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE
Mefloquine,Molecule Z,Drug,Malaria,Malaria,Phase 2,2003-03-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Healthy male or female volunteers who provided informed consent (a healthy volunteer was defined as one who was free of ailments that might cause difficulty in evaluating drug e...",Yes,2004-02-23,FDA-60688,4.41,0.98,21,26.39,2007-07-28,2008-07-20,2029-07-20,49,Merck,48,Overall,41.83333333,34,7,46,24,58,82,36,1,2,1,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE
NMRC-M3V-Ad-PfCA,Product Alpha,Biological,Malaria,Malaria,Phase 2,2017-09-25,"Sex: ALL; Age: >18 Years; Criteria: INCLUSION CRITERIA:

* Between the ages of 18-50 (inclusive)
* Negative results of HIV ELISA, HbSAg, anti-HCV antibody, and no other clinically significant abnormal laboratory results from screening.
...",No,2018-05-07,FDA-30690,4.41,0.98,21,26.39,2022-02-21,2023-02-14,2044-02-14,97,Bayer,61,Kenya,47.33333333,47,12,93,23,14,95,55,1,3,2,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
Atovaquone Proguanil,Comp Beta,Drug,Malaria,Malaria,Phase 2,2010-04-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* A male or non-pregnant, non-lactating female 18 to 50 years of age (inclusive) at the time of screening
* Free of clinically significant health problems
* Baseline ECG before en...",Yes,2010-08-22,FDA-92732,4.41,0.98,21,26.39,2014-08-28,2015-08-21,2036-08-20,23,Gilead,80,South Africa,30.83333333,16,0,8,68,49,44,45,2,1,2,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE
Artemether / Lumefantrine,TradeName X,Drug,Malaria,Malaria,Phase 2,2022-08-17,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Provision of signed or thumb printed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Ma...",No,2022-09-25,FDA-57296,4.41,0.98,21,26.39,2027-01-13,2028-01-06,2049-01-05,58,Pfizer,31,Senegal,46.33333333,9,48,21,91,39,70,18,0,2,0,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
Dihydroartemisinin-piperaquine (DHA/Pip),AltName B,Drug,Malaria,Malaria,Phase 2,2022-08-17,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Provision of signed or thumb printed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Ma...",Yes,2023-01-11,FDA-99817,4.41,0.98,21,26.39,2027-01-13,2028-01-06,2049-01-05,38,GSK,99,Kenya,68.5,90,45,83,75,85,33,45,1,2,2,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE
Standard AED,Molecule Z,Drug,Malaria,Malaria,Phase 2,2015-06-01,"Sex: ALL; Age: >24 Months; Criteria: Inclusion Criteria:

* Comatose with Blantyre Comas Score ² 2
* P. falciparum parasitemia via thick blood film or rapid diagnostic test
* Active seizure in past 24 hours

Exclusion Criteria:

* Serum ...",No,2016-04-07,FDA-77855,4.41,0.98,21,26.39,2019-10-28,2020-10-20,2041-10-20,67,Novartis,98,Overall,53.33333333,52,55,32,93,4,84,36,0,3,1,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE
Oral Levetiracetam,Product Alpha,Drug,Malaria,Malaria,Phase 2,2015-06-01,"Sex: ALL; Age: >24 Months; Criteria: Inclusion Criteria:

* Comatose with Blantyre Comas Score ² 2
* P. falciparum parasitemia via thick blood film or rapid diagnostic test
* Active seizure in past 24 hours

Exclusion Criteria:

* Serum ...",No,2016-03-04,FDA-35830,4.41,0.98,21,26.39,2019-10-28,2020-10-20,2041-10-20,94,Novartis,37,Overall,63,57,93,79,69,52,28,27,1,1,1,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE
Placebo/TMPS,Comp Beta,Drug,Malaria,Malaria,Phase 2,2022-01-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

* Confirmed HIV-infection (documented in medical record)
* Age ³16 years
* Confirmed pregnancy, \<28 weeks estimated gestational age (by best obstetric estimate which may include ...",Yes,2022-11-12,FDA-88320,4.41,0.98,21,26.39,2026-05-30,2027-05-23,2048-05-22,82,Merck,60,South Africa,46.16666667,78,27,33,56,72,11,73,2,4,2,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
Azithromycin/TMPS,AltName B,Drug,Malaria,Malaria,Phase 2,2022-01-01,"Sex: FEMALE; Age: >16 Years; Criteria: Inclusion Criteria:

* Confirmed HIV-infection (documented in medical record)
* Age ³16 years
* Confirmed pregnancy, \<28 weeks estimated gestational age (by best obstetric estimate which may include ...",Yes,2022-07-13,FDA-42775,4.41,0.98,21,26.39,2026-05-30,2027-05-23,2048-05-22,23,Bayer,22,Overall,39,65,67,12,4,48,38,73,2,4,2,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
"RTS,S/AS01E Fractional dose",AltName B,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",No,2018-08-04,FDA-18232,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,29,Sanofi,43,Senegal,45.33333333,35,22,78,57,62,18,0,0,0,0,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"RTS,S/AS01E + DHA-PIP+PQ Fractional dose",AltName A,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",No,2018-11-14,FDA-32846,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,66,Pfizer,44,Senegal,63.66666667,71,72,44,61,52,82,45,1,1,3,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE
"RTS,S/AS01E + DHA-PIP+PQ Fractional two-dose",GenName Y,Biological,Malaria,Malaria,Phase 2,2018-02-20,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Participant is a healthy male or non-pregnant female, aged 18 to 55 years (inclusive), of Thai origin.
* Participant is willing and able to give informed consent to participate ...",Yes,2019-02-12,FDA-97578,4.41,0.98,21,26.39,2022-07-19,2023-07-12,2044-07-11,68,AstraZeneca,10,Senegal,51.83333333,29,64,81,40,64,33,73,1,3,4,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
OZ439,GenName Y,Drug,Malaria,Malaria,Phase 2,2012-05-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

1. Male or female patients between the age of 18 and 60 years, inclusive
2. Body weight between 40 kg and 90 kg inclusive
3. Presence of mono-infection of P. falciparum or P. viva...",No,2013-02-09,FDA-88556,4.41,0.98,21,26.39,2016-09-27,2017-09-20,2038-09-20,4,Sanofi,50,Overall,52.66666667,12,29,91,23,85,76,64,1,3,3,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE
MMV390048,Comp Beta,Drug,Malaria,Malaria,Phase 2,2018-09-24,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Body weight between 40 kg and 90 kg inclusive
* Presence of P. vivax or P. falciparum monoinfection confirmed by:
* Fever, as defined by axillary temperature ³37.5¡C or oral/rec...",No,2019-05-11,FDA-81349,4.41,0.98,21,26.39,2023-02-20,2024-02-13,2045-02-12,37,Bayer,51,South Africa,41.5,33,2,88,33,71,22,45,1,2,2,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE
Sanaria¨ PfSPZ Vaccine,AltName A,Biological,Malaria,Malaria,Phase 2,2022-12-10,"Sex: ALL; Age: >6 Years; Criteria: Inclusion Criteria:

1. Parent(s) or guardian(s) willing and able to provide consent prior to initiation of any study procedures
2. Stated willingness of parent(s) or guardian(s) to comply with all st...",Yes,2023-04-09,FDA-18978,4.41,0.98,21,26.39,2027-05-08,2028-04-30,2049-04-30,87,Novartis,56,Senegal,40,33,12,96,1,72,26,18,0,1,1,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE
Chloroquine + Primaquine,TradeName X,Drug,Malaria,Malaria,Phase 2,2005-01-10,"Sex: ALL; Age: >20 Years; Criteria: Inclusion Criteria:

1. Positive smear for P. vivax.
2. Parasite density \> 500 and \< 200,000/_l
3. Age: 20-60 years old
4. Willing to sign consent form
5. Willing to be hospitalized for 29 days and ...",No,2005-06-15,FDA-71651,4.41,0.98,21,26.39,2009-06-08,2010-06-01,2031-06-01,8,Bayer,65,Kenya,68.5,3,74,77,63,97,97,55,2,4,0,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE
LEVETIRACETAM,Product Alpha,Drug,Malaria,Malaria,Phase 2,2013-07-01,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Comatose with Blantyre Comas Score ² 3
* P. falciparum parasitemia
* Active seizure

Exclusion Criteria:

* Serum creatinine \> 2mg/dL
* Pre-admission/concomitant treatment with...",Yes,2014-04-10,FDA-19059,4.41,0.98,21,26.39,2017-11-27,2018-11-20,2039-11-20,17,GSK,91,Kenya,37.5,37,30,36,76,24,22,36,2,2,0,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE
tafenoquine,Product Alpha,Drug,Malaria,Malaria,Phase 2,2005-01-10,"Sex: ALL; Age: >20 Years; Criteria: Inclusion Criteria:

1. Positive smear for P. vivax.
2. Parasite density \> 500 and \< 200,000/_l
3. Age: 20-60 years old
4. Willing to sign consent form
5. Willing to be hospitalized for 29 days and ...",No,2005-03-01,FDA-27077,4.41,0.98,21,26.39,2009-06-08,2010-06-01,2031-06-01,43,AstraZeneca,77,Kenya,39.33333333,62,29,8,59,48,30,45,2,0,3,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE
Acetaminophen,Product Alpha,Drug,Malaria,Malaria,Phase 2,2022-12-02,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Evidence of Plasmodium falciparum malaria infection by peripheral blood smear or rapid diagnostic test
* Central nervous system (CNS) symptoms associated with malaria. CEREBRAL ...",Yes,2023-01-29,FDA-85841,4.41,0.98,21,26.39,2027-04-30,2028-04-22,2049-04-22,76,Novartis,78,Kenya,44.83333333,98,18,66,34,53,0,64,1,4,2,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
Ibuprofen,AltName A,Drug,Malaria,Malaria,Phase 2,2022-12-02,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Evidence of Plasmodium falciparum malaria infection by peripheral blood smear or rapid diagnostic test
* Central nervous system (CNS) symptoms associated with malaria. CEREBRAL ...",Yes,2023-04-15,FDA-61406,4.41,0.98,21,26.39,2027-04-30,2028-04-22,2049-04-22,28,AstraZeneca,35,Senegal,40.33333333,78,37,25,81,17,4,64,0,3,4,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
placebo for acetaminophen,Product Alpha,Drug,Malaria,Malaria,Phase 2,2022-12-02,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Evidence of Plasmodium falciparum malaria infection by peripheral blood smear or rapid diagnostic test
* Central nervous system (CNS) symptoms associated with malaria. CEREBRAL ...",Yes,2023-10-01,FDA-35005,4.41,0.98,21,26.39,2027-04-30,2028-04-22,2049-04-22,35,Novartis,97,Senegal,40,41,29,87,14,68,1,36,1,0,3,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE
placebo for ibuprofen,TradeName X,Drug,Malaria,Malaria,Phase 2,2022-12-02,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

* Evidence of Plasmodium falciparum malaria infection by peripheral blood smear or rapid diagnostic test
* Central nervous system (CNS) symptoms associated with malaria. CEREBRAL ...",Yes,2023-04-05,FDA-39462,4.41,0.98,21,26.39,2027-04-30,2028-04-22,2049-04-22,17,GSK,26,Senegal,33,19,13,59,39,10,58,45,1,2,2,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE
"RTS,S/AS02D",TradeName X,Biological,Malaria,Malaria,Phase 2,2007-12-27,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant of between 6 and 12 weeks of age at the time of first vaccination.
* Written informed consent obtained from the parent(s) or guardian(s) of the subject
*...",Yes,2008-05-16,FDA-83144,4.41,0.98,21,26.39,2012-05-24,2013-05-17,2034-05-17,60,AstraZeneca,89,Senegal,39.16666667,83,10,73,3,56,10,45,0,3,2,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE
Stamarilª,Product Alpha,Biological,Malaria,Malaria,Phase 2,2009-10-07,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Signed or thumb-printed informed consent obtained from the parent(s)/guardian(s) of the...",Yes,2010-07-04,FDA-60434,4.41,0.98,21,26.39,2014-03-05,2015-02-26,2036-02-26,87,Pfizer,71,Kenya,40.83333333,48,78,93,4,2,20,82,0,5,4,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE
M5717 330 mg,Comp Beta,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2024-08-08,FDA-74209,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,70,AstraZeneca,74,Overall,48.16666667,40,69,10,80,37,53,27,1,0,2,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE
Tritanrix HepB Hib,Product Alpha,Biological,Malaria,Malaria,Phase 2,2014-12-23,"Sex: ALL; Age: >1 Day; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female infant between 1 and 7 days (inclusive) of age (where day 1 is day of birth).
* Signed or thum...",No,2015-11-07,FDA-92173,4.41,0.98,21,26.39,2019-05-21,2020-05-13,2041-05-13,98,J&J,80,South Africa,24.16666667,61,15,3,53,11,2,45,1,3,1,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
Abhayrab rabies vaccine,TradeName X,Biological,Malaria,Malaria,Phase 2,2022-08-17,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Provision of signed or thumb printed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Ma...",No,2023-08-05,FDA-27870,4.41,0.98,21,26.39,2027-01-13,2028-01-06,2049-01-05,70,Merck,29,South Africa,65.5,47,99,85,13,63,86,0,0,0,0,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
Engerix-B,Product Alpha,Biological,Malaria,Malaria,Phase 2,2014-12-23,"Sex: ALL; Age: >1 Day; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female infant between 1 and 7 days (inclusive) of age (where day 1 is day of birth).
* Signed or thum...",No,2015-07-21,FDA-58442,4.41,0.98,21,26.39,2019-05-21,2020-05-13,2041-05-13,92,GSK,49,Kenya,46.66666667,10,71,75,96,9,19,36,1,2,1,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE
AQ-13 Treatment,Molecule Z,Drug,Malaria,Malaria,Phase 2,2017-02-01,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria

1. Adult Malian males ³ 18 years of age,
2. Uncomplicated malaria with ³ 2,000 asexual P. falciparum parasites per ul, and
3. Informed consent obtained and signed.

Exclusion Crite...",No,2017-11-08,FDA-13275,4.41,0.98,21,26.39,2021-06-30,2022-06-23,2043-06-23,45,GSK,69,South Africa,49.83333333,53,29,50,43,69,55,36,1,1,2,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
Coartem Treatment,Molecule Z,Drug,Malaria,Malaria,Phase 2,2017-02-01,"Sex: MALE; Age: >18 Years; Criteria: Inclusion Criteria

1. Adult Malian males ³ 18 years of age,
2. Uncomplicated malaria with ³ 2,000 asexual P. falciparum parasites per ul, and
3. Informed consent obtained and signed.

Exclusion Crite...",No,2018-01-20,FDA-99287,4.41,0.98,21,26.39,2021-06-30,2022-06-23,2043-06-23,72,AstraZeneca,68,Kenya,55.83333333,5,83,90,44,72,41,45,1,2,2,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE
"RTS,S/AS01B",AltName B,Biological,Malaria,Malaria,Phase 2,2018-09-24,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Written informed consent obtained from the subject prior to perfor...",No,2019-01-03,FDA-14918,4.41,0.98,21,26.39,2023-02-20,2024-02-13,2045-02-12,80,Bayer,37,South Africa,39.83333333,65,75,0,7,88,4,27,1,2,0,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
M5717 500 mg,AltName A,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2024-08-30,FDA-65429,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,94,AstraZeneca,61,Kenya,51.83333333,65,68,57,56,65,0,64,2,4,1,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE
Falciparum Malaria Protein 11 with AS02A adjuvant,Molecule Z,Biological,Malaria,Malaria,Phase 2,2007-04-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* A male or non-pregnant female 18 to 50 years of age (inclusive) at the time of screening.
* Written informed consent obtained from the subject before screening procedures.
* Fre...",Yes,2007-09-24,FDA-94720,4.41,0.98,21,26.39,2011-08-28,2012-08-20,2033-08-20,24,Gilead,24,Overall,45.5,15,10,96,9,77,66,45,1,3,1,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE
M5717 660 mg,GenName Y,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2025-04-05,FDA-65674,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,64,Pfizer,31,Overall,54.33333333,20,57,86,84,54,25,27,0,2,1,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE
Pyronaridine 360 mg,Comp Beta,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2024-09-16,FDA-41417,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,22,GSK,34,Senegal,39,64,64,2,31,35,38,36,1,3,0,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
Pyronaridine 540 mg,Product Alpha,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2024-10-09,FDA-97946,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,40,Novartis,70,Kenya,38.66666667,84,43,5,67,7,26,45,0,3,2,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
Pyronaridine 720 mg,AltName A,Drug,Malaria,Malaria,Phase 2,2024-05-28,"Sex: ALL; Age: >12 Years; Criteria: Inclusion Criteria:

* Participants with microscopic confirmation of acute uncomplicated Plasmodium falciparum using Giemsa-stained thick and thin film
* P. falciparum parasitemia of 1,000 to 50,000 a...",No,2024-10-03,FDA-71482,4.41,0.98,21,26.39,2028-10-24,2029-10-17,2050-10-17,9,Sanofi,43,Kenya,47.66666667,80,52,1,41,47,65,55,1,3,2,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
PvDBPII/Matrix-M1,AltName A,Biological,Malaria,Malaria,Phase 2,2022-07-14,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Healthy adult aged 18 to 45 years.
* Red blood cells positive for the Duffy antigen/chemokine receptor (DARC).
* Normal serum levels of Glucose-6-phosphate dehydrogenase (G6PD)....",No,2022-11-28,FDA-52258,4.41,0.98,21,26.39,2026-12-10,2027-12-03,2048-12-02,67,GSK,34,South Africa,54.33333333,75,40,20,86,57,48,45,1,2,2,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
Pb(PfCS@UIS4)-infected mosquitoes,Comp Beta,Biological,Malaria,Malaria,Phase 2,2018-10-03,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

1. Subject is aged ³ 18 and ² 35 years and in good health.
2. Subject has adequate understanding of the procedures of the study and is able and willing (in the investigator's opin...",No,2019-07-17,FDA-74980,4.41,0.98,21,26.39,2023-03-01,2024-02-22,2045-02-21,48,Bayer,93,South Africa,73.16666667,80,86,90,75,71,37,36,0,3,1,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE
"RTS,S/AS01E",Comp Beta,Biological,Malaria,Malaria,Phase 2,2018-09-24,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Written informed consent obtained from the subject prior to perfor...",No,2018-11-25,FDA-42718,4.41,0.98,21,26.39,2023-02-20,2024-02-13,2045-02-12,92,Sanofi,46,Senegal,47.33333333,1,43,78,72,90,0,36,1,2,1,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE
BCG,GenName Y,Biological,Malaria,Malaria,Phase 2,2014-12-23,"Sex: ALL; Age: >1 Day; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female infant between 1 and 7 days (inclusive) of age (where day 1 is day of birth).
* Signed or thum...",No,2015-08-26,FDA-50622,4.41,0.98,21,26.39,2019-05-21,2020-05-13,2041-05-13,24,GSK,7,Overall,65.16666667,24,36,87,67,86,91,45,1,3,1,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE
OPV,AltName B,Biological,Malaria,Malaria,Phase 2,2014-12-23,"Sex: ALL; Age: >1 Day; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female infant between 1 and 7 days (inclusive) of age (where day 1 is day of birth).
* Signed or thum...",No,2015-12-22,FDA-53953,4.41,0.98,21,26.39,2019-05-21,2020-05-13,2041-05-13,62,Merck,92,South Africa,20,9,26,29,16,13,27,0,0,0,0,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
Rouvax,Molecule Z,Biological,Malaria,Malaria,Phase 2,2014-12-23,"Sex: ALL; Age: >1 Day; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A male or female infant between 1 and 7 days (inclusive) of age (where day 1 is day of birth).
* Signed or thum...",Yes,2015-09-14,FDA-49074,4.41,0.98,21,26.39,2019-05-21,2020-05-13,2041-05-13,50,Merck,78,Senegal,41,60,16,83,23,1,63,36,1,2,1,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE
Chloroquine Phosphate,Comp Beta,Drug,Malaria,Malaria,Phase 2,2021-02-10,"Sex: ALL; Age: >18 Years; Criteria: * INCLUSION CRITERIA:
* Age greater than or equal to 18 and less than or equal to 50 years (for booster phase, age greater than or equal to 18 and less than or equal to 52 years)
* Resident of Bancoum...",Yes,2021-04-20,FDA-96145,4.41,0.98,21,26.39,2025-07-09,2026-07-02,2047-07-02,41,Gilead,5,Kenya,30.33333333,50,36,7,35,24,30,27,0,2,1,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE
Polio Sabinª,Comp Beta,Biological,Malaria,Malaria,Phase 2,2009-10-07,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Signed or thumb-printed informed consent obtained from the parent(s)/guardian(s) of the...",Yes,2010-08-20,FDA-10626,4.41,0.98,21,26.39,2014-03-05,2015-02-26,2036-02-26,29,J&J,52,South Africa,47.83333333,73,59,47,10,14,84,64,0,3,4,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE
Malarone,TradeName X,Drug,Malaria,Malaria,Phase 2,2007-10-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Adult male \& non-pregnant females, 18-65 years
* Fever, defined as \>37.5¼C, during the current illness, or history (within the last 48 hours) of fever.
* Diagnosis of falcipar...",Yes,2008-02-27,FDA-56552,4.41,0.98,21,26.39,2012-02-27,2013-02-19,2034-02-19,19,Pfizer,41,Kenya,55.5,53,53,94,3,60,70,55,1,4,1,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
Tritanrixª HepB/Hib,Product Alpha,Biological,Malaria,Malaria,Phase 2,2009-10-07,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Signed or thumb-printed informed consent obtained from the parent(s)/guardian(s) of the...",No,2010-09-21,FDA-71419,4.41,0.98,21,26.39,2014-03-05,2015-02-26,2036-02-26,69,Sanofi,80,South Africa,37.16666667,7,47,8,52,79,30,55,1,3,2,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE
GSK 257049,GenName Y,Biological,Malaria,Malaria,Phase 2,2009-10-07,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Signed or thumb-printed informed consent obtained from the parent(s)/guardian(s) of the...",No,2010-07-12,FDA-86878,4.41,0.98,21,26.39,2014-03-05,2015-02-26,2036-02-26,55,Merck,58,Kenya,51.16666667,42,92,16,14,58,85,36,1,0,3,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE
p52-/p36- GAP Vaccine,Molecule Z,Biological,Malaria,Malaria,Phase 2,2011-06-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* A male or non-pregnant, non-lactating female 18 to 50 years of age (inclusive) at the time of enrollment
* Free of significant health problems as established by medical history,...",No,2011-08-17,FDA-45160,4.41,0.98,21,26.39,2015-10-28,2016-10-20,2037-10-20,13,Pfizer,25,Kenya,51.83333333,21,100,39,25,98,28,18,1,0,1,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE
p52-p36- GAP Vaccine,TradeName X,Biological,Malaria,Malaria,Phase 2,2011-06-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* A male or non-pregnant, non-lactating female 18 to 50 years of age (inclusive) at the time of enrollment
* Free of significant health problems as established by medical history,...",No,2011-10-25,FDA-16165,4.41,0.98,21,26.39,2015-10-28,2016-10-20,2037-10-20,38,Bayer,98,Kenya,82.33333333,96,76,98,60,83,81,45,0,5,0,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
DSM265,Product Alpha,Drug,Malaria,Malaria,Phase 2,2016-05-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

Health status:

* Certified as healthy by a comprehensive clinical assessment (detailed medical history and complete physical examination).
* Normal vital signs after 5 minutes re...",No,2016-07-31,FDA-66367,4.41,0.98,21,26.39,2020-09-27,2021-09-20,2042-09-20,53,Novartis,65,Senegal,57.33333333,10,96,73,13,84,68,55,2,3,1,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE
Ferroquine SSR97193,GenName Y,Drug,Malaria,Malaria,Phase 2,2019-09-23,"Sex: ALL; Age: >6 Months; Criteria: Inclusion criteria:

Male or female participant aged greater than (\>) 6 months old and \<70 years old:

* Cohort 1 = 14 years \< age \<70 years and body weight greater than or equal to (\>=) 35 kilog...",Yes,2020-08-26,FDA-84271,4.41,0.98,21,26.39,2024-02-19,2025-02-11,2046-02-11,94,AstraZeneca,22,Overall,50.5,9,71,1,95,33,94,36,0,4,0,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
Artefenomel,TradeName X,Drug,Malaria,Malaria,Phase 2,2019-09-23,"Sex: ALL; Age: >6 Months; Criteria: Inclusion criteria:

Male or female participant aged greater than (\>) 6 months old and \<70 years old:

* Cohort 1 = 14 years \< age \<70 years and body weight greater than or equal to (\>=) 35 kilog...",Yes,2020-01-30,FDA-90517,4.41,0.98,21,26.39,2024-02-19,2025-02-11,2046-02-11,74,Merck,4,Senegal,73.5,80,63,99,73,57,69,73,2,2,4,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE
L9LS,AltName B,Drug,Malaria,Malaria,Phase 2,2024-06-02,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria

Healthy children aged 5 months to 10 years (Part 1) or 5-59 months (Part 2). Weight ³5 kg and weight ²30 kg (Part 1) or weight ³5 kg and ²22.5 kg (Part 2) or weight ³5 kg and ²20 k...",No,2025-01-14,FDA-29095,4.41,0.98,21,26.39,2028-10-29,2029-10-22,2050-10-22,7,Pfizer,93,South Africa,42.5,20,73,35,87,26,14,55,1,3,2,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE
ibuprofen,GenName Y,Drug,Malaria,Malaria,Phase 2,2021-02-10,"Sex: ALL; Age: >18 Years; Criteria: * INCLUSION CRITERIA:
* Age greater than or equal to 18 and less than or equal to 50 years (for booster phase, age greater than or equal to 18 and less than or equal to 52 years)
* Resident of Bancoum...",Yes,2021-04-03,FDA-17236,4.41,0.98,21,26.39,2025-07-09,2026-07-02,2047-07-02,35,GSK,70,Senegal,61.16666667,98,76,3,5,93,92,73,1,4,3,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE
Pyrimethamine,TradeName X,Drug,Malaria,Malaria,Phase 2,2021-02-10,"Sex: ALL; Age: >18 Years; Criteria: * INCLUSION CRITERIA:
* Age greater than or equal to 18 and less than or equal to 50 years (for booster phase, age greater than or equal to 18 and less than or equal to 52 years)
* Resident of Bancoum...",Yes,2021-06-10,FDA-28323,4.41,0.98,21,26.39,2025-07-09,2026-07-02,2047-07-02,13,Novartis,87,South Africa,52.16666667,98,53,45,76,41,0,64,2,4,1,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE
PfSPZ Challenge,Product Alpha,Biological,Malaria,Malaria,Phase 2,2021-02-10,"Sex: ALL; Age: >18 Years; Criteria: * INCLUSION CRITERIA:
* Age greater than or equal to 18 and less than or equal to 50 years (for booster phase, age greater than or equal to 18 and less than or equal to 52 years)
* Resident of Bancoum...",Yes,2021-07-17,FDA-88023,4.41,0.98,21,26.39,2025-07-09,2026-07-02,2047-07-02,55,AstraZeneca,24,Overall,57.83333333,88,42,72,43,27,75,55,0,3,3,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE
(+)-SJ000557733 (SJ733),AltName B,Drug,Malaria,Malaria,Phase 2,2022-04-15,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

1. Male or female, aged 18 to 70 years of age (inclusive) at screening.
2. Body weight between 45 kg and 90 kg inclusive
3. Presence of mono-infection of P. falciparum or P. vivax...",Yes,2022-10-26,FDA-22276,4.41,0.98,21,26.39,2026-09-11,2027-09-04,2048-09-03,5,Novartis,96,Kenya,39,15,7,65,60,43,44,36,1,2,1,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE
TETRActHibª,TradeName X,Biological,Malaria,Malaria,Phase 2,2007-12-27,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion Criteria:

* A male or female infant of between 6 and 12 weeks of age at the time of first vaccination.
* Written informed consent obtained from the parent(s) or guardian(s) of the subject
*...",Yes,2008-09-28,FDA-83813,4.41,0.98,21,26.39,2012-05-24,2013-05-17,2034-05-17,61,Bayer,27,Overall,44.66666667,85,49,36,15,81,2,36,1,2,1,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE
Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine,TradeName X,Biological,Malaria,Malaria,Phase 2,2008-11-11,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* A male or female child of between 5 months and 17 months of age at the time of first vaccination.
* Written or oral, signed or thumb-printed and witnessed informed consent obtai...",Yes,2009-06-10,FDA-27474,4.41,0.98,21,26.39,2013-04-09,2014-04-02,2035-04-02,61,J&J,93,Kenya,60.33333333,10,78,75,100,71,28,36,0,2,2,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE
VRC-MALMAB0100-00-AB (CIS43LS),AltName B,Biological,Malaria,Malaria,Phase 2,2023-07-05,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Aged ³18 and ²55 years.
* Able to provide proof of identity to the satisfaction of the study clinician completing the enrollment process.
* In good general health and without cl...",Yes,2024-02-23,FDA-76095,4.41,0.98,21,26.39,2027-12-01,2028-11-23,2049-11-23,31,Merck,45,Overall,34.16666667,43,15,53,8,50,36,36,0,4,0,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
"RTS,S/AS01E (Full dose)",AltName B,Biological,Malaria,Malaria,Phase 2,2022-11-14,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* Participants' parent(s)/LAR(s) who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g. return for follow-up visits).
* Signed or...",No,2023-06-17,FDA-75711,4.41,0.98,21,26.39,2027-04-12,2028-04-04,2049-04-04,73,Sanofi,84,Overall,54.66666667,87,49,3,79,94,16,45,1,2,2,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE
Rabipur,TradeName X,Biological,Malaria,Malaria,Phase 2,2008-05-30,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* A male or female child between 5 months and 17 months of age at the time of first vaccination.
* Written or oral, signed or thumb-printed and witnessed informed consent obtained...",Yes,2009-03-11,FDA-74942,4.41,0.98,21,26.39,2012-10-26,2013-10-19,2034-10-19,27,Novartis,58,Senegal,28.16666667,22,43,43,1,50,10,36,1,2,1,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE
GSK malaria vaccine 257049 Vaccine,AltName B,Biological,Malaria,Malaria,Phase 2,2008-11-11,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* A male or female child of between 5 months and 17 months of age at the time of first vaccination.
* Written or oral, signed or thumb-printed and witnessed informed consent obtai...",Yes,2009-02-04,FDA-86262,4.41,0.98,21,26.39,2013-04-09,2014-04-02,2035-04-02,60,J&J,11,Overall,76.16666667,100,78,67,69,96,47,55,1,3,2,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE
Pfs230D1M-EPA/AS01,AltName B,Biological,Malaria,Malaria,Phase 2,2022-10-31,"Sex: ALL; Age: >1 Year; Criteria: * INCLUSION CRITERIA FOR GROUPS 1,2,3:

All of the following criteria must be fulfilled for a volunteer to participate in this trial:

1. Meets age requirements for Arm currently being enrolled.
2. Av...",No,2023-01-08,FDA-44611,4.41,0.98,21,26.39,2027-03-29,2028-03-21,2049-03-21,35,Pfizer,90,Kenya,40.66666667,40,36,13,66,65,24,64,1,3,3,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE
L9LS (VRC-MALMAB0114-00-AB) intravenous injection,Product Alpha,Biological,Malaria,Malaria,Phase 2,2024-04-20,"Sex: ALL; Age: >6 Years; Criteria: Inclusion Criteria:

* Is within the appropriate age range for the respective cohort:

  1. Children: Aged ³6 years and \<11 years.
  2. Adults: Aged ³18 years.
* Able to provide proof of identity to ...",No,2024-08-07,FDA-59409,4.41,0.98,21,26.39,2028-09-16,2029-09-09,2050-09-09,40,J&J,95,Senegal,59.83333333,27,66,99,81,42,44,55,1,3,2,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
L9LS (VRC-MALMAB0114-00-AB) Subcutaneous injection,Comp Beta,Biological,Malaria,Malaria,Phase 2,2024-04-20,"Sex: ALL; Age: >6 Years; Criteria: Inclusion Criteria:

* Is within the appropriate age range for the respective cohort:

  1. Children: Aged ³6 years and \<11 years.
  2. Adults: Aged ³18 years.
* Able to provide proof of identity to ...",No,2024-07-16,FDA-86450,4.41,0.98,21,26.39,2028-09-16,2029-09-09,2050-09-09,61,J&J,58,Senegal,52.5,69,24,94,44,10,74,45,0,3,2,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE
Engerix-B¨,AltName B,Biological,Malaria,Malaria,Phase 2,2009-01-15,"Sex: ALL; Age: >6 Weeks; Criteria: Inclusion criteria:

* A male or female infant between 6 and 10 weeks of age at the time of first vaccination.
* Written or oral, signed or thumb-printed and witnessed informed consent obtained from t...",No,2009-08-08,FDA-65515,4.41,0.98,21,26.39,2013-06-13,2014-06-06,2035-06-06,2,J&J,33,Kenya,42.5,63,58,8,68,5,53,45,1,2,2,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE
Pyronaridine-Artesunate,Product Alpha,Drug,Malaria,Malaria,Phase 2,2006-12-01,"Sex: ALL; Age: >2 Years; Criteria: Inclusion Criteria:

Patients presenting with symptoms of acute uncomplicated falciparum malaria with the following inclusion criteria:

* Male or female children, being between 2 and 14 years of age ...",No,2007-03-25,FDA-53396,4.41,0.98,21,26.39,2011-04-29,2012-04-21,2033-04-21,23,Sanofi,52,Kenya,53.16666667,17,95,15,92,2,98,55,1,2,3,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE
RabAvert,AltName B,Biological,Malaria,Malaria,Phase 2,2007-06-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A healthy male or female child, 12 to 47 months of age on the day of screening
* Written informed consent obtai...",No,2007-10-14,FDA-74295,4.41,0.98,21,26.39,2011-10-28,2012-10-20,2033-10-20,91,Pfizer,100,Senegal,42.5,29,16,78,12,53,67,55,0,4,2,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE
FMP1/AS02A,Molecule Z,Biological,Malaria,Malaria,Phase 2,2007-06-01,"Sex: ALL; Age: >12 Months; Criteria: Inclusion Criteria:

All subjects must satisfy the following criteria at study entry:

* A healthy male or female child, 12 to 47 months of age on the day of screening
* Written informed consent obtai...",Yes,2008-04-22,FDA-66725,4.41,0.98,21,26.39,2011-10-28,2012-10-20,2033-10-20,34,Bayer,20,Senegal,38.5,33,35,97,38,15,13,45,0,1,4,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE
Rabies Vaccine,Molecule Z,Biological,Malaria,Malaria,Phase 2,2009-07-01,"Sex: ALL; Age: >1 Year; Criteria: Inclusion Criteria:

* Age 1-6 years inclusive at the time of screening
* Residing in Bandiagara town
* Appear to be in generally good health based on clinical and laboratory investigation
* Separate ...",Yes,2009-11-17,FDA-56938,4.41,0.98,21,26.39,2013-11-27,2014-11-20,2035-11-20,94,J&J,96,Kenya,53.83333333,75,40,42,11,86,69,73,2,3,3,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE
FMP2.1/AS02A,TradeName X,Biological,Malaria,Malaria,Phase 2,2009-07-01,"Sex: ALL; Age: >1 Year; Criteria: Inclusion Criteria:

* Age 1-6 years inclusive at the time of screening
* Residing in Bandiagara town
* Appear to be in generally good health based on clinical and laboratory investigation
* Separate ...",Yes,2010-05-07,FDA-77096,4.41,0.98,21,26.39,2013-11-27,2014-11-20,2035-11-20,20,Merck,94,Kenya,39.66666667,49,16,53,64,22,34,73,1,4,3,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE
HAVRIX,TradeName X,Biological,Malaria,Malaria,Phase 2,2022-10-31,"Sex: ALL; Age: >1 Year; Criteria: * INCLUSION CRITERIA FOR GROUPS 1,2,3:

All of the following criteria must be fulfilled for a volunteer to participate in this trial:

1. Meets age requirements for Arm currently being enrolled.
2. Av...",Yes,2023-09-13,FDA-41983,4.41,0.98,21,26.39,2027-03-29,2028-03-21,2049-03-21,72,Sanofi,66,Senegal,46,23,11,90,94,33,25,73,2,4,2,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE
TYPHIM Vi (Salmonella typhi vaccine),TradeName X,Biological,Malaria,Malaria,Phase 2,2022-10-31,"Sex: ALL; Age: >1 Year; Criteria: * INCLUSION CRITERIA FOR GROUPS 1,2,3:

All of the following criteria must be fulfilled for a volunteer to participate in this trial:

1. Meets age requirements for Arm currently being enrolled.
2. Av...",Yes,2023-02-15,FDA-98339,4.41,0.98,21,26.39,2027-03-29,2028-03-21,2049-03-21,50,Bayer,2,Senegal,50.66666667,84,33,68,23,22,74,55,1,3,2,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
Menactra,AltName B,Biological,Malaria,Malaria,Phase 2,2022-10-31,"Sex: ALL; Age: >1 Year; Criteria: * INCLUSION CRITERIA FOR GROUPS 1,2,3:

All of the following criteria must be fulfilled for a volunteer to participate in this trial:

1. Meets age requirements for Arm currently being enrolled.
2. Av...",Yes,2023-10-12,FDA-58549,4.41,0.98,21,26.39,2027-03-29,2028-03-21,2049-03-21,21,Bayer,82,Kenya,47.83333333,6,87,35,91,18,50,36,1,0,3,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE
AVAXIM,TradeName X,Biological,Malaria,Malaria,Phase 2,2022-10-31,"Sex: ALL; Age: >1 Year; Criteria: * INCLUSION CRITERIA FOR GROUPS 1,2,3:

All of the following criteria must be fulfilled for a volunteer to participate in this trial:

1. Meets age requirements for Arm currently being enrolled.
2. Av...",No,2023-01-28,FDA-63452,4.41,0.98,21,26.39,2027-03-29,2028-03-21,2049-03-21,97,GSK,61,Kenya,29,7,20,47,33,27,40,45,1,3,1,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
Amodiaquine,Comp Beta,Drug,Malaria,Malaria,Phase 2,2015-07-01,"Sex: ALL; Age: >2 Years; Criteria: * INCLUSION CRITERIA

  1. Age 2 to 10 years, inclusive
  2. Resident of Kenieroba
  3. Uncomplicated malaria\*
  4. P. falciparum density 10,000 70,000/micro L, inclusive
  5. Willingness to particip...",Yes,2016-01-05,FDA-24734,4.41,0.98,21,26.39,2019-11-27,2020-11-19,2041-11-19,1,Sanofi,76,South Africa,55.33333333,18,95,14,65,69,71,45,0,5,0,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
Actidose Aqua,Product Alpha,Drug,Malaria,Malaria,Phase 2,2015-07-01,"Sex: ALL; Age: >2 Years; Criteria: * INCLUSION CRITERIA

  1. Age 2 to 10 years, inclusive
  2. Resident of Kenieroba
  3. Uncomplicated malaria\*
  4. P. falciparum density 10,000 70,000/micro L, inclusive
  5. Willingness to particip...",Yes,2016-04-10,FDA-94706,4.41,0.98,21,26.39,2019-11-27,2020-11-19,2041-11-19,89,Gilead,45,Senegal,54,75,89,65,14,25,56,45,1,3,1,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE
L9LS (VRC-MALMAB0114-00-AB),AltName B,Biological,Malaria,Malaria,Phase 2,2024-02-11,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

1. Females aged ³18 and ²49 years and weighing ³ 45.0 and ² 90.0 kg.
2. Males aged ³18 and ²55 years and weighing ³ 50.0 and ² 100.0 kg.
3. Able to provide proof of identity to th...",No,2024-11-14,FDA-61951,4.41,0.98,21,26.39,2028-07-09,2029-07-02,2050-07-02,24,Merck,33,Overall,47.83333333,18,89,2,81,53,44,82,2,3,4,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE
Artefenomel (OZ439),Product Alpha,Drug,Malaria,Malaria,Phase 2,2019-11-06,"Sex: ALL; Age: >14 Years; Criteria: Inclusion criteria :

Participants (14-69 years old inclusive) with body weight within 35 and 90 kilograms (kg), with uncomplicated Plasmodium falciparum (P. falciparum) malaria, with a fever as defin...",No,2019-12-07,FDA-58535,4.41,0.98,21,26.39,2024-04-03,2025-03-27,2046-03-27,61,Novartis,41,Senegal,54.16666667,3,17,83,67,80,75,64,1,3,3,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE
Ferroquine (SSR97193),TradeName X,Drug,Malaria,Malaria,Phase 2,2019-11-06,"Sex: ALL; Age: >14 Years; Criteria: Inclusion criteria :

Participants (14-69 years old inclusive) with body weight within 35 and 90 kilograms (kg), with uncomplicated Plasmodium falciparum (P. falciparum) malaria, with a fever as defin...",No,2020-10-24,FDA-88652,4.41,0.98,21,26.39,2024-04-03,2025-03-27,2046-03-27,44,Bayer,27,Overall,45.16666667,32,30,86,28,0,95,55,1,3,2,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE
GSK257049 Dosage 2,Comp Beta,Biological,Malaria,Malaria,Phase 2,2014-12-16,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

Inclusion criteria for enrolment to the primary phase:

* Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* A male or ...",No,2015-04-01,FDA-98114,4.41,0.98,21,26.39,2019-05-14,2020-05-06,2041-05-06,85,Sanofi,12,Kenya,53.33333333,28,59,77,25,84,47,45,0,1,4,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE
GSK257049 Dosage 1,Product Alpha,Biological,Malaria,Malaria,Phase 2,2014-12-16,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

Inclusion criteria for enrolment to the primary phase:

* Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* A male or ...",Yes,2015-01-28,FDA-40431,4.41,0.98,21,26.39,2019-05-14,2020-05-06,2041-05-06,21,GSK,86,Overall,50.33333333,11,74,62,53,17,85,55,0,3,3,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE
Rabies vaccine,TradeName X,Biological,Malaria,Malaria,Phase 2,2022-11-14,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* Participants' parent(s)/LAR(s) who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g. return for follow-up visits).
* Signed or...",Yes,2023-08-23,FDA-62889,4.41,0.98,21,26.39,2027-04-12,2028-04-04,2049-04-04,60,Sanofi,85,Senegal,51.5,4,91,89,52,48,25,64,2,3,2,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE
"RTS,S/AS01E (1/5th dose)",AltName A,Biological,Malaria,Malaria,Phase 2,2022-11-14,"Sex: ALL; Age: >5 Months; Criteria: Inclusion Criteria:

* Participants' parent(s)/LAR(s) who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g. return for follow-up visits).
* Signed or...",Yes,2023-06-07,FDA-73486,4.41,0.98,21,26.39,2027-04-12,2028-04-04,2049-04-04,33,AstraZeneca,1,Overall,41.83333333,94,30,18,33,7,69,64,2,2,3,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
pyronaridine/artesunate,Product Alpha,Drug,Malaria,Malaria,Phase 2,2006-04-01,"Sex: ALL; Age: >15 Years; Criteria: Inclusion Criteria:

1. Male or female patients between the age of 15 and 60 years of age inclusive
2. Written informed consent, in accordance with local practice, provided by patient and/or parent/gu...",Yes,2006-10-13,FDA-54580,4.41,0.98,21,26.39,2010-08-28,2011-08-21,2032-08-20,47,GSK,14,Kenya,44.16666667,99,7,82,6,71,0,36,0,2,2,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE
R21/Matrix-M1,GenName Y,Biological,Malaria,Malaria,Phase 2,2017-02-15,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

The volunteer must satisfy all the following criteria to be eligible for the study:

* Healthy adults ages 18 to 45 years.
* Willingness to remain in study area for the period of ...",Yes,2017-10-08,FDA-72076,4.41,0.98,21,26.39,2021-07-14,2022-07-07,2043-07-07,4,Gilead,17,South Africa,34.83333333,48,27,82,5,18,29,45,1,2,2,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE
Falciparum Malaria Protein 11 with AS01B adjuvant.,Molecule Z,Biological,Malaria,Malaria,Phase 2,2007-04-01,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* A male or non-pregnant female 18 to 50 years of age (inclusive) at the time of screening.
* Written informed consent obtained from the subject before screening procedures.
* Fre...",No,2007-07-28,FDA-94558,4.41,0.98,21,26.39,2011-08-28,2012-08-20,2033-08-20,16,Merck,77,Overall,34,7,13,61,55,22,46,64,2,2,3,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE
"Malaria Vaccine RTS,S/AS01E",AltName B,Biological,Malaria,Malaria,Phase 2,2022-08-17,"Sex: ALL; Age: >18 Years; Criteria: Inclusion Criteria:

* Provision of signed or thumb printed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Ma...",No,2023-08-01,FDA-49352,4.41,0.98,21,26.39,2027-01-13,2028-01-06,2049-01-05,30,Bayer,59,Overall,53.33333333,84,30,86,72,1,47,45,0,2,3,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE